Research Experience for Undergraduates Program, 2007 by University of Arkansas, Fayetteville. Dept. of Chemistry and Biochemistry
University of Arkansas, Fayetteville 
ScholarWorks@UARK 
Research Experience for Undergraduates Chemistry and Biochemistry 
2007 
Research Experience for Undergraduates Program, 2007 
University of Arkansas, Fayetteville. Dept. of Chemistry and Biochemistry 
Follow this and additional works at: https://scholarworks.uark.edu/chbc-research-experience 
Citation 
University of Arkansas, Fayetteville. Dept. of Chemistry and Biochemistry. (2007). Research Experience for 
Undergraduates Program, 2007. Research Experience for Undergraduates. Retrieved from 
https://scholarworks.uark.edu/chbc-research-experience/4 
This Periodical is brought to you for free and open access by the Chemistry and Biochemistry at 
ScholarWorks@UARK. It has been accepted for inclusion in Research Experience for Undergraduates by an 
authorized administrator of ScholarWorks@UARK. For more information, please contact ccmiddle@uark.edu. 
 
 
 
University of Arkansas 
Research Experience for Undergraduates 
________________________________________ 
 
Summer 2007 
Research Reports 
 
 
 
 
 
 
 
 
 
 
Research Experience for 
Undergraduates 
2007 
 
 
Department of Chemistry and 
Biochemistry University of Arkansas 
 
 
 
Donald R. Bobbitt and David W. Paul 
Program Co-Directors 
 
Supported by the National Science 
Foundation 
 
 
 
 
Table of Contents 
 
 
REU – University of Arkansas ............................................................................ 1 
 
Tony Jude Award ................................................................................................. 2 
 
2007 REU Participants ......................................................................................... 3 
 
Faculty Project List .............................................................................................. 4 
 
Schedule of Events ............................................................................................... 5 
 
Project Reports ..................................................................................................... 9 
 
 Karole Blythe ............................................................................................. 9 
 
 Sherri Brixey............................................................................................ 16 
 
 Jahnavi Chatterjee ................................................................................... 28 
 
 Charles Loftis .......................................................................................... 35 
 
 Carrie Peter .............................................................................................. 53 
 
 Michelle Reed .......................................................................................... 66 
 
 Adam Ring ............................................................................................... 81 
 
 Roger Williams ........................................................................................ 89 
 
 Lauren Woods........................................................................................ 107 
 
 1 
 
 
Research Experience for Undergraduates 
University of Arkansas 
 
 
 The University of Arkansas Department of Chemistry and Biochemistry hosted a 
National Science Foundation sponsored Research Experience for Undergraduates (REU) summer 
program for the 19th year.  The department first hosted an REU in 1959.  The 10-week summer 
program, funded by the National Science Foundation, allowed students an opportunity to gain 
hands-on experience in a chosen research area while introducing them to careers in scientific 
research in areas including analytical chemistry and sensor technology, biochemistry and protein 
dynamics, inorganic chemistry and nanotechnology, organic chemistry, and physical and 
theoretical chemistry. 
 
 Undergraduate chemistry majors, who were sophomores or juniors in fall 2006, applied 
to the program, which took place in the Ozark Mountain Plateau. 
 
 Outside the lab, students met each week to hear presentations from campus experts about 
topics ranging from how to get into graduate school and test-taking skills to ethics, and how to 
make a poster presentation.  A number of social activities took place throughout the summer to 
give students a chance to interact. 
 
 Selected students received a scholarship to pay for room and board and an allowance to 
attend a regional or national chemical conference in the 2007-2008 academic year.  Students 
involved in the program were enrolled as students at the U of A and received one hour of 
research credit.  The program was conducted from May 21, 2007 to July 27, 2007. 
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Tony Jude Award 
 
 Arkansas native Roger Williams, a student at Eastern New Mexico University, was the 
recipient of the Tony Jude Award for his research under the direction of Distinguished Professor 
Bob Gawley.  He is featured next to his poster entitled “Synthesis & Racemization Studies of 
Chiral Pyrrolidines.” 
 
 The Tony Jude Award recognizes a student for outstanding research.  It is in memory of a 
former REU student who returned to the University of Arkansas and obtained a doctorate degree. 
 
 
 
 
Tony Jude Award Winner Roger Williams with REU co-director David Paul 
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REU Students 2007 
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Faculty Project List 
 
Paul Adams 
Assistant Professor 
Biophysical characterization of proteins associated with signal 
transduction 
Neil Allison 
Associate Professor and Vice-
Chair 
Organometallic chemistry, pentadienoyl chemistry, transition metal 
metallacycles 
Dan Davis 
Professor 
Photosynthesis, biophysics 
Bill Durham 
Professor and Chair 
Photochemistry of metal complexes, electron transfer reactions of 
metalloproteins 
Ingrid Fritsch 
Professor 
Miniaturized analytical devices, bioanalytical, electrochemistry, 
surface modification, microfluidics 
Bob Gawley 
Distinguished Professor 
Organic chemistry – dynamics, structure, and reactivity of  chiral 
organometallics, sensor design, dendrimers, natural products 
Roger Koeppe 
University Professor 
Membrane biophysics, voltage-dependent ion channels, design of 
membrane-spanning peptides, protein engineering and drug design 
T.K.S. Kumar 
Assistant Professor 
Protein 3-D structure, dynamics, folding and interactions 
Matt McIntosh 
Associate Professor 
Synthetic organic chemistry, natural products synthesis 
Frank Millett 
Distinguished Professor 
Biological electron transfer, cytochromes, biophysics 
David Paul 
Associate Professor 
Chemical sensors, instrumentation 
Xiaogang Peng 
Associate Professor 
Nano-technology, nano-crystalline materials 
Peter Pulay 
Distinguished Professor 
Ab initio methods, biophysics, parallel computing 
Josh Sakon 
Associate Professor 
Protein crystallography, biophysics 
Derek Sears 
University Professor 
Cosmochemistry 
Wesley Stites 
Associate Professor 
Protein chemistry, protein folding, biophysics 
Z. Ryan Tian 
Assistant Professor 
Hierarchical and ordered nanostructures for catalytic, sensing, and 
biomaterial applications 
Charles Wilkins 
Distinguished Professor 
Fourier transform nuclear magnetic resonance, infrared, and mass 
spectrometry, laboratory computer applications in chemical 
instrumentation, fundamentals of gas phase ion-molecule reactions, 
bioanalytical chemistry 
Jack Lay 
Director, Statewide Mass 
Spectrometry Facility 
Collaborates with other investigators that need mass spectrometry 
measurements and develops new methods for analysis of chemical 
and biologicals 
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University of Arkansas 
 NSF – CHEMISTRY – REU - SUMMER 2007 
Activities and Events 
 
Sunday, May 20 
1:00 p.m. – 4:00 p.m. Arrival, Check-In & Registration 
Holcombe Hall (front desk: (479)718-3702 
Parking Registration 
 
6:00 p.m. – 9:00 p.m. Welcome Dinner 
University House, Penguin Ed’s Barbeque 
 
Monday, May 21 
8:00 a.m. – 8:45 a.m. Breakfast 
    Quad Dinning Room (you must pay cash) 
 
8:45 a.m.   Meet in quad lobby to go to university together 
 
9:00 a.m. – 10:00 a.m. Group Photo 
Front of Library 
 
10:00 a.m. – 12:00 p.m. Campus Logistics (Concurrent Sessions) 
 
RED  Session I:    10:00-10:50 a.m.    Session II:  11:00-11:50 a.m.   
YELLOW  Session II:   10:00-10:50 a.m.    Session I:   11:00-11:50 a.m.   
 
Session I:    Cash Checks, ID Cards Issued, Parking tags 
Arkansas Union  
Parking and Transit available:  $15 per parking tag. 
May park in lots 35 and 70 Monday and Tuesday.  
Tag needs to be displayed by Wednesday to avoid 
ticketing. 
Session II:   Library Orientation 
University of Arkansas Mullins Library 
 
 
12:00 p.m. - 1:30 p.m. Opening Luncheon 
    Place: Donald W. Reynolds Center, Seminar Room A 
Speaker:  Dr. Don Bobbitt, Dean 
Fulbright College of Arts and Sciences 
 
1:30 p.m. – 2:30 p.m. Campus Tour (Ending at Union) 
 
2:30 p.m. – 4:30 p.m. Departmental Logistics, 
Place:  Chemistry Building 
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Safety Briefing: Bill Durham, Department Chair 
    Meet your Mentor: Refreshments will be served 
    Get Keys, Take Photos 
 
Tuesday, May 22  Leadership/Team Building Activity (Includes Lunch) 
9:00 a.m. – 3:00 p.m. Graduate Education Building Auditorium, Room 166 
Professor Ken Vickers 
Balance of day free for logistics.  Banking, Keys, etc. 
 
Wednesday, May 23 Go to Your Lab and Get Started! 
8:00 a.m.    
 
4:30 p.m. – 6:00 p.m. Dinner & Dialogue 
    Place: Reynolds Center, Seminar Room A 
Speaker:  Dr. Collis Geren, Dean of the Graduate School & 
Vice Provost for Research 
Topic: “Little Brown Spider” 
 
Friday, May 25  REU Meeting 
1:00 p.m.   CHEM 105 
    Speaker:  Dr. Don Bobbitt, Dean of the College of Arts & 
Sciences 
    Topic:  Ethics 
 
Saturday, May 26 – Monday May 28   Free for Memorial Day Weekend 
 
Wednesday, May 30 Dinner & Dialogue 
4:30 p.m. – 6:00 p.m. Place:  Graduate Education Auditorium Building, Room 166 
    Speaker: Panel of former REU and Carver grad students 
Topic: Panel Discussion 
     
Friday, June 1  REU Meeting 
1:00 p.m.   CHEM 105 
    Speaker:  Dr. Robert Gawley 
    Topic:  Chirality 
 
Wednesday, June 6 Dinner & Dialogue 
4:30 p.m. – 6:00 p.m. Place:  Reynolds Center, Seminar Room A 
    Speaker:  Dr. Robert Brady, Department Chair – 
Communications 
    Topic:  Presentation Skills 
 
Thursday, June 7  Evening Entertainment 
6:00 p.m. – 9:00 p.m. Host: Microelectronics-Photonics 
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Friday, June 8  REU Meeting 
1:00 p.m.   CHEM 105 
    Speaker:  TBA 
    Topic:  TBA 
 
Monday, June 11  Canoe Trip 
 
 
Wednesday, June 13 Dinner & Dialogue 
4:30 p.m. – 6:00 p.m. Place: Reynolds Center, Seminar Room A 
    Speaker:  Dr. Dennis Brewer, Associate Vice-Provost for 
Research 
Topic:  Research & Ethics 
 
Thursday, June 14  Evening Entertainment 
6:00 p.m. – 9:00 p.m. Host: Physics 
    Location:  Concert at the Park 
 
Friday, June 15  REU Meeting 
1:00 p.m.   CHEM 105 
    Speaker:  Dr. Lothär Schafer 
 
Saturday, June 16  Practice GRE and GMAT test offered 
10 a.m.   AR Union, Rooms 507 & 511.  Testing is FREE  
    Participation requires pre-registration  
    Location:  Bell Engineering, Room 209 
     
Wednesday, June 20 Dinner & Dialogue 
4:30 p.m. – 6:00 p.m. Place: Reynolds Center, Seminar Room A 
    Speaker:  Karla Clark, Graduate Recruiter & Director, GWCRP 
    Topic:  Applying to Graduate School      
     
Thursday, June 21  Evening Entertainment 
6:00 p.m. – 9:00 p.m. Host:  Chemistry 
    Location:  Devils Den 
     
Friday, June 22  REU Meeting 
1:00 p.m.   CHEM 105 
Half-way Progress Reports Due 
 
Thursday, June 28  Evening Entertainment 
6:00 p.m.-9:00 p.m. Host:  Carver 
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Friday, June 29  REU Meeting 
1:00 p.m.   CHEM 105 
    Speaker:  Dr. J. O. Lay, Jr. 
    Topic:  A method for detecting bioterrorism 
 
Saturday, June 30 – Wednesday July 4   Free for Independence Day Weekend 
    You must return to Fayetteville by 8:00 a.m., July 5 
 
Monday, July 9-10   Road Trip, National Lab 
1.5 Days    
      
Wednesday, July 11 Final Carver Presentations 
3:00p.m. – 7:00 p.m.   
 
 
Friday, July 13  REU Meeting 
1:00 p.m.   How to Make a Poster 
    Jennifer Sims, Editor, Chemistry and Biochemistry  
 
Friday, July 20  REU Meeting 
1:00 p.m.   CHEM 105 
    Speaker:  Dr. Charles Wilkins     
 
Thursday, July 26  Meeting in Miniature, Lunch Served 
10:00 a.m.      CHEM 105 
  
Friday,  July 27  End of Program 
5:00 p.m.    Final reports due   
Dorm check-out 
 
Saturday, July 28  End of Program 
a.m.     Get out of the Dorm, last check-out 
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Expression of, and Measurement of the Binding Affinity of Isotopically-
labeled Cdc42 wild type and Cdc42(F28L) with a minimal binding domain 
peptide of a p21-Activated Serine/Threonine Kinase 
Karole Blythe, Langston University 
Langston, Oklahoma 
 
Abstract 
Cdc42 (cell division cycle 42) belongs to the Rho subfamily of the Ras superfamily of G 
proteins (guanine nucleotide binding proteins). The ultimate goal of this research is to 
study the solution structure of an oncogenic mutant of Cdc42, Cdc42(F28L), bound to an 
important effector peptide that regulates Cdc42-induced cell signaling activity using NMR 
Spectrometry. Both wild type and mutant Cdc42 were expressed using an Escherichia coli 
expression system, and purified using immobilized metal affinity chromatograph (IMAC). 
The binding affinity of wild type and mutant was tested by performing a protein pull down 
assay with PBD46, a minimal binding domain peptide of 46 amino acids of PAK (p21- 
activated serine/threonine kinases). The results showed that both the Cdc42 and 
Cdc42(F28L) were both successfully expressed in the minimal media containing the 
isotopic label, 15N-Nitrogen, which id necessary to being NMR studies. Pull down assays 
were performed to determine whether the presence of the 15N-isotopic label affected 
binding of the PBD46 peptide. 
 
Introduction 
Cdc42 (cell division cycle 42) belongs to the Rho subfamily of the Ras superfamily of G 
proteins (guanine nucleotide binding proteins). Ras proteins can be found in most cell types and 
has many cellular signaling functions, including intracellular trafficking, cytoskeletal 
organization, and protein trafficking. The protein acts as a molecular timing switch undergoing a 
continuous cycle between the GTP (Guanosine triphosphate)-bound active form, and the GDP 
(Guanosine diphosphate)-bound inactive form. One known mutant of the protein, Cdc42(F28L) 
(Cell Division Cycle 42 phenylalanine to leucine) has a lowered affinity for the bound 
nucleotide, and therefore GDP-GTP exchange occurs at a faster rate, causing cellular 
transformation. 
The ultimate goal of this research is to understand the structure of Cdc42(F28L)-PBD46 
complex relative to the wildtype-PBD46 complex using NMR (nuclear magnetic resonance) 
spectroscopy. Pull down assays were performed with Cdc42(F28L) to see how it binds to 
PBD46. Assays of Cdc42 wild type with PBD46 were performed as controls. By fully 
understanding the solution structure of the Cdc42(F28L)-PBD complex, molecular aspects 
outlining the different signaling activity in this mutant Cdc42 construct can be uncovered. 
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Experimental Procedure 
Frozen stock of Escherichia coli containing the plasmid for Cdc42 was thawed and used 
to streak an Ampicillin-resistant agar plate. The plate incubated over night at 37° C. A single 
colony was chosen from the plate to be inoculated along with ampicillin into a 10ml flask of 
complex media (yeast broth). The flask incubated overnight at 37° C while being shaken, 
allowing the bacteria to grow. The next day the broth was inoculated into a one liter volume of 
the yeast broth along with more ampicillin, and incubated and shaken at 37° C. When the optical 
density of the broth, which was monitored using a Diode Array Detector, reached .6 (about 4 
hours later) the cells were induced with IPTG (Isopropyl β-D-1-thiogalactopyranoside). It was 
placed back on the shaker overnight at 37° C. Before the induction took place 1 ml of the broth 
was taken, put into an eppendorf tube, marked pre- induction, and put into the refrigerator to be 
later used as a control for a 12.5% SDS PAGE (sodium dodecyl sulfate polyacrylamide gel)  
analysis of protein expression. Another 1 ml sample was taken two hours after induction, placed 
into eppendorf  tubes, marked 2 hour post- induction and refrigerators to be used later in the 
12.5% SDS PAGE to analyze the cell expression after two hour. The next day another 1 ml 
sample was taken and marked over night; it was saved to later analyze protein expression over 
night. The cells were then harvested by centrifuging the broth at 10,000 rpm for 15 minutes at 4° 
C. The supernatant was decanted and the pellets were placed into the -80° C freezer. The process 
stated above, in its entirety, was then repeated to express Cdc42(F28L).  
The six samples previously taken (both from Cdc42 and Cdc42(F28L)) were centrifuged 
and the supernatant discarded. The pellets were resuspended in phosphate buffered saline. The 
tubes marked two hour post induction and over night were then sonicated, each receiving 5 
pulses, and incubated on ice for one hour. The samples were then frozen in the -80° C freezer, 
thawed at room temperature, sonicated, frozen, and thawed again. Once thawed, a 50µl sample 
was taken out from each, placed into an eppendorf and marked total protein. The remainder of 
the sample was centrifuged, the pellet became the insoluble portion, and the supernatant was 
decanted into another container and marked soluble portion. The pellets were resuspended in 
solubilization buffer. Concentrated solubilization buffer was added to the total protein and 
soluble portions. 10µl of the samples were loaded into a 12.5% SDS PAGE, a gel for each of the 
protein types. A molecular weight pre-stained ladder (Control) was also included in each of the 
gels. The gels were run on an electrophoresis at a constant voltage of 250 volts for 35 minutes. 
The gel is then stained with coomassie blue and left on a shaker.  
The minimal media (M9 Minimal Media with 15N) labeling was prepared. Ammonium 
Chloride was added to the media to incorporate the isotopic label. 20ml cultures containing yeast 
broth, ampicillin, and the protein (samples were taken from previously saved protein in glycerol 
stock) for both the wild type and mutant were started and shaken at 37° C over night. The culture 
was inoculated into a two liter volume of the M9 media along with more ampicillin. The culture 
was left to shake and incubate at 37° C. The cells were induced with IPTG when the optical 
density reached about .6. The M9 media hinders cell growth due to the lack of nutrients; 
therefore, it took roughly 8 hours for the desired optical density to be reached. After induction 
the media was left to shake over night at 37° C. The cells were then harvested and the pellets left 
in the -80° C freezer. The pellets were thawed and resuspended in 5mM Imidazole buffer. GDP 
(guanosine diphosphate), lysozyme, deoxycholic acid, PMSF (phenylmethylsulphonyl fluoride), 
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apoprotein, and leupeptin were added to help lyse the cells. The entire contents were mixed on 
ice for one hour, after which DNase (deoxyribonuclease) was added and once again mixed for an 
hour on ice. The mixture was decanted into centrifuge tubes and spun down at 18,000 rpm for 30 
minutes at 4° C. The supernatant was kept and marked either wild type or mutant lysate.  
The lysate was pumped into a column containing nickel sepharose beads. The his- tag 
(histidine-tag) on the protein bonds to the beads. 5mM Imidozale and 25mM Imidozale buffers 
were pumped into the column to wash through any non specific binding. The protein was washed 
off the beads using 250mM Imidozale buffer. The purified protein was collected in fractions. 25 
µl of each fraction were taken and used to run 12.5% SDS PAGE to analyze the expression level 
of the protein. The fractions that contained the protein were combined and diluted with 20mM 
Tris buffer. The entire sample was concentrated using a protein concentrator, diluted again, and 
re- concentrated. The process was repeated four times. This process served as a buffer change 
because the affinity of the 250mM Imidozale is very strong and would therefore interfere with 
the pull down assay.  
The Pull Down assay was performed using glutathion beads with the purified proteins 
and cell lysate that contained expressed PBD46 with GST (glutathione S-transferase) tag. Cell 
lysate that contained expressed GST tag only was used as nonspecific binding control.  The 
addition of the .5mM GMPPCP (GTP(β,γ-CH2)) is necessary for maximum binding of the 
Cdc42 and PBD46.  
They were six samples for both the wild type and mutant proteins. The samples were 
GST (1ml), GST + purified protein (.5ml), GST + purified protein + GMPPCP (30 µl), GST- 
PBD (1ml), GST-PBD + purified protein (.5ml), and GST-PBD + purified protein + GMPPCP 
(30 µl). The samples were mixed in the cold room for one hour. The glutathione beads (50 µl of 
a 1:1 mixture of beads in phosphate buffer saline) were added to each of the samples and the 
mixing continued for thirty additional minutes. Vacuum filtration was used to remove the liquid, 
keeping only the beads. Solubilization buffer was added to the beads, followed by the samples 
being centrifuged.  
 A western blot and 12.5% SDS PAGE was run to analyze the results of the pull down 
assay. The first antibody used to detect the Cdc42 for the western blot was the anti-his mouse 
antibody. The second antibody used to detect the anti- his mouse antibody was goat anti-mouse 
IgG (Immunoglobulin G) alkaline phosphate.   
 
 
 
 
 
 12 
Results and Discussion 
Figure 1 
Figure 2   
 
Figure one corresponds to the 12.5% SDS PAGE test expression of Cdc42. Figure two 
corresponds to the test expression of Cdc42(F28L). Both wild type and mutant have been 
successfully expressed. There are lanes showing, pre- induction (pre-indu), two hour post 
induction (labeled 2hr- postindu ) which is separated into total protein (T), soluble (S), and 
insoluble (in-S). There is also lanes showing overnight expression (ONT- postindu), which are 
separated into the same categories as the two hour post induction. A molecular weight pre-
stained ladder (Control) was also included in each of the gels. One of the bands indicated on the 
molecular weight ladder is about 20 kiloDaltons, the approximate weight of the mutant and wild 
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type proteins expressed. The yield of the wild type protein increases when it is left to incubate 
over night after induction. The wild type is also mostly soluble. The mutant protein is mostly 
insoluble. The soluble portion of the protein almost completely degrades with over night 
incubation after induction. The mutant is not as stable as the wild type.  
 
Figure 3 
Figure three corresponds to three separate 12.5% SDS PAGES run to show the wild type 
and mutant protein expression in the M9 media. A molecular weight pre-stained ladder (Control) 
was once again included. Samples were taken before purification for the Ccd42 and after 
purification for both the proteins. The proteins were purified using an IMAC. The band that 
corresponds to about 20 kiloDaltons is marked to show the approximate area where the wild type 
and mutant bands should appear. The expression levels of both the wild type and mutant were 
fairly low. The mutant expression was considerably lower than the wild type. This can be seen 
by the lack of intensity in the band. 
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Figure 4-1     Figure 4-2 
Figure four- one shows the results of the western blot. It indicates a positive binding 
affinity between 15N  labeled CDC42 and PBD46. The results shown are only for the wild type. 
The mutant was poorly expressed in the M9 media and was not detected by the gel or the western 
blot; therefore it was omitted in the data collection. The isotopic label, incorporated in the wild 
type, did not interfere with its ability to bind to the PAK protein. The addition of the GMPPCP 
was a key factor for maximum binding of the Cdc42 and PBD46, therefore creating a bold 
detection band on the membrane. The 12.5% SDS PAGE, figure four-two, shows that the same 
amount of GST and GST- PBD46 were used to bind and pull down the CDC42.  
Conclusion 
Important information about the expression level of the wild type and mutant was 
gathered in the test expression. The wild type protein was produced more with incubation over 
night after induction, while the mutant starts to degrade over time. The wild type is also mostly 
soluble, while the mutant is mostly insoluble. The Cdc42 and Cdc42 (F28L) were both 
successfully expressed in the M9 media containing the isotopic label. The pull down assay for 
the Cdc42 was a success, which shows that the isotopic label does not enable the protein from 
carrying out its normal functions. The concentration of the mutant was too low to gather 
evidence of binding. 
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Future Plans 
15N-labeled Cdc42(F28L) will again be expressed in the M9 media, and then  purified. 
The Cdc42 will have the his-tag cleaved and its nucleotide successfully exchanged from GDP to 
GMPPCP. The pull down assay will have to be repeated so that a positive pull down assay for 
the mutant can be achieved. The NMR spectrum of the Cdc42-PBD complex will then be taken 
and analyzed to begin the solution structure determination.   
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Understanding the Metal Binding Affinity of the C2B Domain of 
Synaptotagmin 1 
Sherri Brixey, University of Arkansas 
Fayetteville, Arkansas 
 
 
Abstract 
  
The human acidic fibroblast growth factor (FGF-1), a potent mitogen, is involved in a wide 
variety of biological activities including regulation of embryotic development, angiogenesis, 
inflammation, tumor formation, and tissue regeneration.  FGF-1, a 17-kDa protein, lacks 
the conventional hydrophobic N-terminal signal sequence and is therefore secreted through 
non-classical export routes.  Under stress, FGF-1 forms a biologically inactive homodimer 
and is released into the extracellular compartment as a multi-protein complex containing 
the FGF-1 homodimer, S100A13, and synaptotagmin (Syt-1).  Synaptotagmin-1 (p40) plays 
a key role in the regulation of the release of FGF-1.   Copper is known to be important for 
the formation and assembly of the multi-protein complex.  Although the formation of the 
multi-protein release complex is shown to occur in the inner leaflet of the membrane, the 
exact mechanism of the non-classical release of FGF-1 is still an enigma.  Syt-1, a 65-kDa 
synaptic vesicular protein, contains two C-terminal domains, C2A and C2B.  The C2A 
domain has been shown to bind both calcium (Ca2+) and copper (Cu2+) ions.  Studies have 
suggested that cooperation between the C2A and C2B domains exists in the role of Syt-1 as 
a Ca2+ sensor.   However, the metal binding sites of the C2B domain have not been 
characterized.  Further investigation and characterization of the Ca2+ and Cu2+ binding 
affinities of the C2B domain is critical towards understanding the role of Syt-1 and will 
provide useful information towards understanding the role of Cu2+ in the regulation of 
FGF-1 under stress conditions.  In this context, the present study is aimed at examining the 
metal-ion binding affinity of the C2B domain of Syt-1. 
 
Introduction 
 
The human acidic fibroblast growth factor (FGF-1), a potent mitogen, is a prototypical 
member of the FGF family (1).    Fibroblast growth factors (FGFs) are ~17-kDa all-β-sheet 
proteins and are involved in a wide variety of biological activities including regulation of 
embryotic development, angiogenesis, inflammation, tumor formation, and tissue regeneration 
(2).  Most members of the FGF family possess hydrophobic N-terminal signal sequences which 
enable them to be secreted through the classical endoplasmic reticulum and Golgi apparatus 
pathway.  However, FGF-1 lacks this N-terminal signal sequence and is released through non-
classical export routes (2-4).   
 
The precise mechanism for the secretion of the signal peptide-less proteins is not 
completely understood.  FGF-1 release does not occur under normal conditions.  Several studies 
show FGF-1 is released in response to stresses such as heat shock, hypoxia, cultivation under 
low serum conditions, and cell treatment with low-density lipoproteins (LDLs) (5-8).  Studies by 
Jackson et al. (5) demonstrated that the formation of the Cys30-mediated FGF-1 homodimer is 
required for the release of FGF-1 in response to heat shock and hypoxia.  The FGF-1 homodimer 
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has been shown to be biologically inactive.  This dimer formation is believed to be a mechanism 
of storing and transporting FGF-1 in its inactive form (9, 10).  It has been shown that copper 
(Cu2+) oxidation is essential to induce the formation of this FGF-1 homodimer.  The copper 
chelator tetrathiomolybate (TTM) was demonstrated to decrease the rate of stress-induced 
release of FGF-1 (10).  This release of FGF-1 occurs as a component of a multi-protein complex 
which contains the copper-binding proteins S100A13 and the extravesicular domain of p65 
synaptotagamin, p40Syt-1 (9). 
 
Synaptotagmin-1 is a synaptic vesicle protein containing  a short intravesicular N-
terminus, a transmembrane region, a linker sequence, and two C-terminal  calcium-binding 
domains known as C2A and C2B (11-15).  It is believed that p40Syt-1 is produced by proteolytic 
cleavage of p65 near its transmembrane domain (16, 17).   P65Syt-1 displays a classical N-
terminal signal peptide in its primary structure and localizes to the ER-Golgi apparatus primarily.  
However, p40Syt-1 lacks the signal peptide and contains a well-distributed cytosolic area (9, 10).  
Both p40Syt1 and S100A13 are shown to be released from cells under normal cell culture 
conditions (10).  In addition, it has been shown that both p40Syt-1 and S100A13 are required for 
the release of FGF-1 into the extracellular compartment (9).  
 
Many studies have been conducted on the C2A domain of Syt-1.  The C2A domain is an 
18-kDa all-β-sheet protein lacking disulfide bonds, and has been noted to bind to 3 equivalents of 
calcium (13-15).  Recent studies conducted by the Kumar group have revealed the high binding 
affinity of Cu2+ for the C2A domain of p40Syt-1 with a slight conformational change occurring 
in the domain upon the Cu2+ binding (18).  In addition, they discovered C2A contains common 
binding site(s) for Ca2+ and Cu2+ (18).  Interestingly, the source of Cu2+ ions required for the 
formation of the FGF-1 release complex remains unknown.  Kumar group concluded that the 
C2A domain appears to provide the Cu2+ ions required for the formation of the release complex 
of FGF-1 (18).  
 
 The role of the C2B domain of synaptotagmin-1 remains unclear.  Ubach et. al.(19) have 
shown that recombinant C2B domain binds Ca2+ and remains monomeric upon binding.  This 
suggests the cooperation between the C2A and C2B domains in the Ca2+ sensor of Syt-1 (19).    
In this context, further investigation and characterization of the Ca2+ and Cu2+ binding affinities 
of the C2B domain is critical in understanding its role in Syt-1, which is indispensable in the 
non-classical release of FGF-1 (9).  Examination of the Ca2+ and Cu2+ binding affinities of the 
C2B domain provides useful information towards understanding the role of Cu2+ in the regulation 
of FGF-1 under stress conditions. 
 
Materials and Methods 
 
The ingredients for Luria Broth (LB) and ampicillin (AMP) were obtained from 
AMERSCO.  Terbium chloride and trypsin were obtained from Sigma Chemical Co. (St. Louis, 
MO).  Glutathione-sepharose was obtained from Amersham Pharmacia Biotech.  All other 
chemicals used were of high-quality analytical grade.  All solutions were prepared in Milli Q 
water.  Unless otherwise noted, all experiments were performed at 25°C in 10 mM Tris HCl 
buffer (pH 7.0) containing 150 mM NaCl.  
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Expression The expression of the C2B domain was carried out in Escherichia coli.  A 1L 
medium was prepared by adding 25 g of LB broth to a 1 L flask and diluting to 1000 mL with 
distilled water.  The medium was sterilized using an autoclave.  Removing 50 mL of the 
sterilized LB medium, an overnight culture was prepared by adding 0.5 mL glycerol stock of 
E.coli containing the C2B-GST insert.  50 µL of 100 mg/mL AMP to the 50 mL LB medium.  
The overnight culture was incubated for 12-14 hours at 37 °C.  After the incubation period, the 
overnight culture was transferred to the remaining LB medium and additional 1000 µL 100 
mg/mL AMP was added.  The culture was incubated and monitored until its optical density (OD) 
at 600 nm reached a range of 0.5-0.6.  Once the desired OD was obtained, 1000 µL 1M IPTG  
was added to the culture.  The culture was incubated 4 hours for the induction process.  After the 
4 hours of incubation, the induced culture was removed from the incubator and centrifuged at 
6,000 rpm for 20 minutes.  The supernatant was discarded, and the pellet was re-suspended using 
30 mL 1X PBS buffer (pH 7.3).   
 
Purification  Glutathione S-transferase (GST)-fused C2B was purified on a GST  column.  
Bacterial suspension containing the overexpressed GST fused C2B domain was disrupted by 
sonication. The lysed culture was centrifuged.  The expressed C2B-GST fusion protein was 
loaded onto a glutathione sepharose column. Protein impurites were removed by elution  with 1X 
PBS buffer (pH 7.3).  The GST tag was cleaved by on-column cleavage using 100 units of 
thrombin (incubated 8-10 hours).  The cleaved C2B domain was eluted from the column using 
1X PBS (pH 7.3).   Protease inhibitors were added to avoid non-specific proteolytic cleavage.  
Desalting of the purified C2B protein was achieved by ultrafiltration using an amicon set-up.  
GST tag was eluted using the glutathione buffer (pH 8.0).  The purified C2B protein dissolved in 
10 mM Tris HCl buffer containing 150 mM NaCl was stored in -20°C.   
 
Fluorescence Spectroscopy All fluorescence experiments were performed using a Hitachi F2500 
spectrofluoremeter with a 10-mm Quartz cell. Slit widths for emission and excitation wavelength 
were set at 2.5 nm and 10 nm.  All thermal denaturation experiments used 60 μM C2B domain 
and 2 mM CaCl2 and 2 mM CuCl2.  An excitation wavelength of 280 nm and emission 
wavelength range from 300-410 nm was used.  All Tb3+ FRET competition experiments used 114 
μM C2B domain.  All emission spectra were acquired between 300-600 nm using an excitation 
wavelength of 285 nm.   
 
Circular Dichroism  All far-UV circular dichroism (CD) experiments were performed using a 
Jasco J-710 spectropolarimeter.  The concentration of the C2B domain  used was 14 µM.  A 0.1 
mm quartz cell was used and the signal was monitored in the wavelength range of 200-250 nm 
with a scan speed of 20 nm /s.  Each spectrum represents an average of 8 scans.  Appropriate 
background corrections were made.  
 
Isothermal Titration Calorimetry (ITC)  Ca2+ and Cu2+ binding to the C2B domain were 
assessed using ITC experiments performed on a VP-ITC calorimeter (Microcal Inc., 
Northampton, MA).  The C2B domain, CaCl2, and CuCl2 solutions were degassed under 
vacuum.  The sample cell contained 111 μM C2B domain dissolved in 10 mM Tris buffer (pH 
7.4) containing 150 mM NaCl for the Ca2+ experiment and 92 μM C2B domain dissolved in 10 
mM Tris buffer (pH 7.5) containing 150 mM NaCl for the Cu2+ experiment.  Solutions of 2 mM 
CaCl2 and 2 mM CuCl2 were prepared in the same Tris buffer and the pH adjusted accordingly.  
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Titrations for each experiment were performed through injections of 3 μL aliquots of 2 mM 
CaCl2 and CuCl2. Protein-free buffer controls was used to correct the resulting titration curves 
and Origin ITC software was used to analyze the data.  The binding constants were obtained 
through isotherms using on-site and sequential binding models.  
 
Dynamic Light Scattering  Dynamic light scattering measurements were performed using a 
Brookhaven Instruments (Holtsville, NY) BI-200SM goniometer and BI-9000AT digital 
autocorrelator.  Solutions were prepared and were filtered (0.2 µm) to remove dust. Each solution 
sample was injected into a thin-walled cylindrical borosilicate glass cuvette (1 cm diameter) and 
placed in a vat filled with decalin as the index matching fluid. All of the measurements were 
carried out at room temperature. The light source was He-Ne ion laser (Spectra Physics, = 632.8 
nm) and photons scattered by the sample were collected by a photomultiplier tube mounted on 
the goniometer arm at 90° to the direction of the incident radiation. The hydrodynamic diameters 
(d) of vesicles were calculated by using the Stokes-Einstein equation d = kBT/3πηD, where kB is 
the Boltzmann constant, T is the absolute temperature, η is the solvent viscosity, and D is the 
diffusion coefficient. CONTIN algorithms were used in the Laplace inversion of the 
autocorrelation function to obtain the size distribution.  The concentration of protein used was 
142 µM.  Stock solutions of CaCl2 where prepared to perform titrations.   
 
Limited Proteolytic Digestion  Limited proteolytic digestion experiments were performed at 25 
°C using trypsin (Sigma Co.) in the absence and presence of 2 mM Ca2+ and 2 mM Cu2+.  
Proteolytic digestions were carried out at an enzyme to protein ratio of 1:10.  The trypsin 
digestions were stopped after time intervals of 15 minutes by addition of the gel loading dye.  
The concentration of protein used was 82 µM.  The products of the protease digestion were 
analyzed using sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE).   
 
Results and Discussion 
 
The C2B domain of p40Syt-1 has a molecular mass of ~17-kDa.  It is critical to 
understand the metal binding affinities of the C2B domain in order to better understand the role 
of p40Syt-1 in the nonclassical secretion pathway of FGF-1.   The C2B domain will be noted as 
C2B hereafter.  
Ca2+ and Cu2+ bind to C2B with high affinity.  Isothermal titration calorimetry allows for the 
direct measurement of the thermodynamic parameters, which provide insight into the nature and 
magnitude governing protein-metal interactions (20).  ITC experiments provide key information 
to enthalpy, affinity, and stoichiometry of protein-ligand binding reactions (22).   ITC 
experiments were conducted to characterize the binding affinity of C2B to the metal ions such as 
Ca2+ and Cu2+.   The binding isotherm for the C2B-Ca2+ interaction is sigmoidal  and best fits to 
a two-site binding model yielding binding constant values of  ~76 nM and ~83 μM  (Figure 1A).  
The binding stoichiometry between the C2B-Ca2+ is 1:1.  The binding reaction between Ca2+ and 
C2B is exothermic and proceeds with a negative enthalpy.  The results of the C2B-Ca2+ ITC 
experiments clearly demonstrate that Ca2+ does bind tightly to the C2B domain.  Interestingly, 
the ITC experiments performed for the C2B-Cu2+ interaction are unique.  The isotherm shows an 
abnormal curve (Figure 1B).  It shows an initial exothermic phase followed by an endothermic 
phase.  It appears that Cu2+ binding occurs in two steps.  The second phase may also represent a 
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conformational change induced by Cu2+ in C2B.  The nature of the isotherm precludes the 
estimation of the binding constants in both the phases.   
Ca2+ and Cu2+appear to bind to the same sites on C2B.  Terbium (Tb3+), a fluorescent probe, is 
known to bind to the Ca2+ binding sites of a protein and induce luminescence in the visible 
region via energy transfer from tryptophan residues (21).  Terbium fluorescence resonance 
energy transfer (FRET) competition experiments were conducted to assess if the two metal ions 
Ca2+ and Cu2+ compete for the same binding sites on the C2B domain. The binding affinity of 
Tb3+ to C2B was monitored by changes in fluorescence intensity at 545 nm (Figure 2A).  In the 
absence of Cu2+, increasing addition of Tb3+ to C2B results in a progressive increase in the 
emission intensity at 545 nm.  The Tb3+ fluorescence plateaus at a concentration of 2 mM Tb3+.  
Further increase in Tb3+ concentration does not significantly increase the fluorescence intensity 
at 545 nm.  In addition, the Tb3+ binding affinity of C2B was measured in the presence of Cu2+.  
Interestingly, there appears to be little or no change in the Tb3+ fluorescence intensity in the 
presence of Cu2+.  These results indicate that both Ca2+ and Cu2+ can bind to the C2B domain.  
However, Cu2+ appears to have a far greater binding affinity to C2B than Ca2+.  The binding of 
Ca2+ and Cu2+ was assessed by changes in the intrinsic tryptophan fluorescence at 340 nm.  C2B 
was titrated with increasing concentrations of Ca2+ in the range 0-1200 µM (Figure 2B).  The 
tryptophan fluorescence at 340 nm is continuously quenched at increasing concentrations of 
Cu2+.  The 340 nm fluorescence is completely quenched at Cu2+ concentration of 600 µM.  At 
saturating concentrations of Tb3+, the intrinsic fluorescence (at 340 nm) shows a similar trend.  
However, the exponentials of the Cu2+-induced fluorescence quenching is significantly different 
in the presence and absence of Tb3+ suggesting that both Cu2+ and Ca2+ bind to the same site in 
the structures of C2B.  The observed differences in the exponentials plausibly reflect a 
competition between Cu2+ and Ca2+ at intermediate Cu2+ concentrations.   
 
The secondary structure of C2B undergoes little or no conformational change(s) upon the 
binding to Ca2+ and Cu2+.  Possible secondary structure conformational changes in C2B induced 
by Ca2+ and Cu2+ were monitored using far-UV CD spectroscopy.  The far-UV CD spectrum of 
C2B shows a characteristic negative ellipticity band minimum at 218 nm for β-sheet proteins.  
C2B appears to be an all- β-sheet protein with no helical segments (Figure 3, curve a).  In the 
presence of Ca2+ and Cu2+, the far UV CD spectra of the C2B domain show little or no change 
suggesting that the backbone conformation of the protein does not alter up on binding to the 
metal ions (Figure 3, curve b and c). 
   
Ca2+ and Cu2+ have opposite effects on the stability of C2B.  Metals such as Ca2+ and Cu2+ are 
not only able to induce conformational changes in proteins but are also able to alter the 
conformational stability of the protein as well (23).  In order to better understand the 
physiological role(s) of metal ions in altering the functional properties of proteins, importance 
lies in the investigation of the effect(s) of metal ion binding (24).  In this context, the influence of 
Ca2+ and Cu2+ on the thermodynamic stability of C2B was examined by thermal denaturation 
monitored by changes in the ratio of 410 nm to the 300 nm fluorescence.   
 
 The fluorescence spectra of C2B in its native state show an emission maximum of 340 
nm and in its denatured state shows an emission maximum of 343nm (Figure 4, inset).  These 
spectra aid in monitoring the global conformational changes that occur during the unfolding of 
 21 
C2B.  Complete unfolding of the protein occurs beyond 50 ºC. The apparent Tm (the temperature 
at which 50% of the protein molecules exist in the unfolded state) was measured for C2B in the 
absence and presence of Ca2+ and Cu2+ (Figure 4).  The Tm for the C2B unfolding reaction is 
49.82 ± 0.057 ºC.  Upon addition of 2 mM Ca2+, the protein appears to undergo little or no 
structural change below 45 ºC.  However, in the temperature range of 45-65 ºC, the unfolding 
process of C2B staggers, and the Tm value increases to 54.05 ± 0.04 ºC.  The increased Tm value 
reveals the stabilization of C2B in the presence of Ca2+.  Interestingly, the addition of 2 mM Cu2+ 
reduces the conformational stability of C2B with a Tm value of 40.94 ± 0.053 ºC.  These results 
demonstrate that Cu2+ binding destabilizes the C2B domain.   
 
Conformational changes have been assayed using limited trypsin digestion.   Conformational 
changes induced upon ligand binding can be detected using limited protease digestion analysis 
(26).  This technique is governed by the accessibility and stereochemistry of the susceptible sites 
on the protein (27).  In this context, limited trypsin digestion analysis was used in the detection 
of possible structural changes induced by Ca2+ and Cu2+.  Trypsin is an apt choice because its 
cleavage sites are located at the carboxyl ends of lysine and arginine residues of proteins.  C2B is 
rich in lysine and arginine, therefore trypsin digestion helps monitor the conformational changes 
induced upon metal binding.  The proteolytic cleavage was monitored by decreases in the 
intensity of the 17-kDa Coomassie blue-stained band for C2B.  In analysis of the SDS-PAGE, 
the formation of two bands became evident as a result of incubation of apo-C2B in 15 minute 
intervals with trypsin (Figure 5A).   Similarly, the SDS-PAGE for Ca2+-bound C2B incubated 
with trypsin demonstrates the same characteristics as the apo-C2B suggesting no conformational 
changes in the C2B domain are induced in the presence of Ca2+ (Figure 5B).  Interestingly, in the 
presence of Cu2+, the protein is cleaved more rapidly than in the Ca2+-bound  and  apo forms.  
These results suggest binding of Cu2+ trigger a subtle conformational change resulting in 
exposure of additional trypsin cleavage sites in C2B.  Therefore, Cu2+ binding destabilizes C2B.  
These results are consistent with the results of the thermal denaturation experiments.   
 
Ca2+ does not change the molecularity of the C2B domain.   Dynamic light scattering (DLS) is 
another effective tool used to characterize the conformational changes of a protein as a result of 
ligand binding (25).  It is a technique that measures the hydrodynamic radius of a protein by 
measuring the diffusion coefficient of the protein in solution (26).  In this context, we used DLS 
experiments to characterize the molecularity of C2B and assess any conformational changes to 
the protein upon Ca2+ binding.  The diameter estimated for the apo form of C2B using the the 
Stokes-Einstein equation was 5.7 nm which corresponds to a molecular weight of about 35 kDa.  
Upon Ca2+ binding, the diameter remained constant revealing that Ca2+ does not change the 
molecularity of the C2B domain (Figure 6).   
 
Conclusions 
 
 The C2B domain was successfully expressed and purified in Escherichia coli.  ITC 
experiments demonstrate that both Ca2+ and Cu2+ bind to the C2B domain with high affinity.  Far 
UV circular dichroism experiments revealed that the C2B is an all beta-sheet protein with no 
helical segments.  Ca2+ and Cu2+ binding appear to have little or no effect on the secondary 
structure of C2B.  Terbium (Tb3+) FRET competition experiments show that Ca2+ and Cu2+ bind 
to the same sites on C2B.  However, Cu2+ appears to bind to C2B domain with a higher affinity 
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than Ca2+.   Thermal denaturation experiments and limited trypsin digestion experiments reveal 
that Ca2+ stabilizes C2B, but Cu2+ destabilizes C2B.  DLS experiments show that in the apo form, 
the C2B domain is a homodimer.  In addition, Ca2+ binding does not appear to change the 
molecularity of the C2B domain.   
 
 This study reveals that the C2B domain possesses both Ca2+ and Cu2+ binding affinities.  
As a result, the C2B domain appears to play an important role in the metal binding activity of 
Syt-1, which is critical in the non-classical secretion pathway of FGF-1.     
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Legends to Figures 
FIGURE 1:  A- Isothermogram representing the binding of Ca2+ ions to the C2B domain. The 
binding isotherm has been best fit to a two-site binding model. The binding constant 
characterizing the Ca2+-C2B interaction equals ~ 76 nM.  The concentration of the protein used 
was 111 µM.  The experiment was performed at 20°C.   B- Isothermogram representing the 
binding of Cu2+ ions to the C2B domain.  The isotherm precludes binding constants due to its 
unique nature in the curve for the Cu2+ binding.  The experiment was performed at 15°C.  The 
upper panels represent the raw data and the lower panels depict the best-fit curve for the raw 
data. 
FIGURE 2: Terbium binding to the C2B domain. A-Titration of apo-C2B with increasing 
concentration of CuCl2 (closed circle).  C2B saturated with Tb3+ and titrated with increasing 
concentrations of CuCl2 (open circle). B-Titration of apo-C2B with increasing concentration of 
TbCl3 (closed circle). C2B saturated with Cu2+ and titrated with increasing concentrations of 
TbCl3 (open circle). The concentration of C2B used was 114µM.  The competition between Ca2+ 
and Cu2+ to bind to the C2B domain was monitored by Tb3+ fluorescence at 545 nm.  The 
excitation wavelength used was 280 nm.  Appropriate blank corrections were made in all spectra. 
FIGURE 3:  Far-UV CD spectra of C2B in the absence (curve a) and presence of 2 mM Ca2+ 
(curve b) and 2 mM Cu2+ (curve c).  The concentration of protein used was 14 µM.  All spectra 
are an average of 8 scans.  All spectra are corrected for background noise. 
FIGURE 4:  Temperature-induced unfolding of the C2B domain in the absence (open circle) 
and in the presence of 2 mM Ca2+ (closed circle) and 2 mM Cu2+ (square).  The inset figure 
shows the fluorescence spectrum of the C2B domain in the native (N) and denatured (D) states.  
The concentration of the protein used was 60 µM.  The excitation and emission slit widths were 
set at 2.5 and 10.0 nm.  Fluorescence spectra were acquired upon excitation at 280nm.   
FIGURE 5: SDS-PAGE analysis of the trypsin digestion products of the C2B domain in the 
absence and presence of Ca2+ and Cu2+.  Lanes 1-7 of each SDS-PAGE represent the progress of 
the trypsin-induced cleavage of the C2B domain after 0 min, 15 min, 30 min, 45 min, 60 min, 75 
min, and 105 min of incubation of C2B with trypsin.   
FIGURE 6: Dynamic light scattering results for Ca2+ titration of the apo-C2B domain.  The 
concentration of protein used was 142 µM.  The hydrodynamic diameters were equivalent to 5.7 
nm suggesting that the protein is in the dimeric form.   
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A Study of Synthesis and Chemistry of Titananthracene  
Jahnavi Chatterjee, Mississippi University for Women 
Columbus, Mississippi 
 
Abstract 
The goal of this project is to synthesize a transition metallaaromatic compound, 
titananthracene, in order to study the fundamental concept of aromaticity and how it 
applies to this class of metallacycles.  Previous unsuccessful attempts have been made to 
synthesize titananthracene by the removal of hydride from dibenzocyclohexa-2,5-diene. 
This experiment aims at replacing the hydride with a TMS group. Removal of the TMS 
group with an anion is expected to form a titanantracene. The first three steps of the 
proposed mechanism have been successfully carried out.  
 
Introduction 
A metallabenzene is a benzene analogue where a methine group (CH) in benzene has 
been replaced by a transition metal. Titananthracene would be classified as a metallaaromatic 
with titanium as the transition metal. The first stable metallabenzene, osmabenzene, was reported 
by Roper et. al in 19821. Several other metallabenzenes like those of osmium, iridium and 
platinum have been reported since that time. Like benzenes, metallabenzenes have been found to 
have a nearly planar structure. Their C-C bond lengths are intermediate between normal C-C 
single and double bonds and are similar to those of benzene (1.39 Ǻ)2, thus fulfilling the 
structural criteria for aromaticity. 1H and 13C NMR spectroscopy of these compounds also 
confirm the typical aromatic properties characteristic of metallabenzenes1. The Allison group has 
investigated the synthesis of such compounds since 1980 and has been successful in preparing 
and studying the physical and chemical properties of metallabenzenes3. In 1982, the following 
mechanism was reported for the formation of a dihydrometallanthracene, a possible precursor to 
the proposed unsaturated metallaanthracene3:  
 
H H
I I
BuLi
H H
Li Li MX2 M
 
 
Figure 1 
 
Dibenzometallacyclohexa-2,5-dienes such as a titanacycle, a hafnacycle and a cobaltacycle have 
been successfully prepared by the Allison group. The removal of hydride from these cycles 
would yield the desired metallaanthracenes3. However, this method was found to be 
unsuccessful. Our planned pathway was an attempt to overcome the problems with proton 
removal by replacing a hydrogen in the saturated position with a TMS group in a titanacycle 
which can be removed with the help of an anion, thus yielding a stable anionic metallaaromatic 
compound, specifically, titananthracene . The proposed mechanism includes ten steps as shown 
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in Figure 2. If the reaction scheme is successfully carried out, the titananthracene produced will 
be the first in its class and will be useful in studying the physical and chemical properties of 
metallaaromatic compounds and further the investigation of stable metallacycles.  
 
Experimental Procedures 
 
2,2’ – Dibromobenzoin – 2-Bromobenzaldehyde was subjected to benzoin condensation 
following the procedure published by Adams and Marvel4. 8.609 g (0.047 moles) of 2-
Bromobenzaldehyde was reacted with 0.645 g (0.009 moles) of potassium cyanide under reflux 
conditions. The solvent used is a mixture of 10 ml of water and 12 ml of 96% EtOH. The 
reaction was run overnight with constant stirring and at a temperature of 105°C, obtained with 
the help of an oil bath. The product obtained (1) is suction filtered, extracted 8 times with water 
and ether and dried over anhydrous magnesium sulfate. The solvent (ether) is rotavapped and the 
product is analyzed by proton NMR (Figure32). The experiment is carried out thrice with the 
same results.  
 
2,2’ – Dibromobenzilic acid –The procedure followed is a modification of a method published 
by Ballard and Dehn5. An oxidation reaction takes place when the benzoin product (4.651 g, 
0.013 moles) is reacted with potassium bromate (2.104 g, 0.013 moles) and potassium hydroxide 
(0.71 g, 0.013 moles) in water (45ml). The experiment is again set up under reflux conditions, 
with constant stirring overnight. The temperature was maintained at 87°C, obtained with the help 
of an oil bath. At the end of the refluxing, the mixture was diluted with water and permitted to 
stand for about 4 hours. Next, a mixture of 6 ml concentrated sulfuric acid and 18 ml water (3 
parts water, 1 part acid) is added in portions. The solid yellowish-white product (1.8 g) obtained 
is filtered by suction filtration and tested by a proton NMR analysis (Figure 4).  
 
2,2’ – Dibromobenzophenone6,7 – 0.521 g (0.014 moles) of the dibromobenzilic acid is further 
reacted with 0.488 g (0.0017 moles) sodium bismuthate and 15 ml of glacial acetic acid as the 
solvent6. The experiment is set up under Argon and is stirred violently for 4-5 hours under a 
constant temperature of 55°C. After stirring, a mixture of 85% phosphoric acid and water is 
added to the reaction vessel and permitted to stand overnight. The organic layer is extracted with 
ether, water and dilute sodium hydroxide solution. The extract is dried over magnesium sulfate 
and the solvent removed. The product obtained is analyzed by proton NMR (Figure 5).  
 
2,2’ – Dibromophenylmethane6,7 – The ketone in the above product undergoes reduction when 
reacted with 55.9% hydroiodic acid (1 ml) and red phosphorus powder (0.13 g, 0.004 moles). A 
reflux is set up with constant stirring for 48 hours. The mixture was then diluted with water, 
extracted with toluene, dried over anhydrous magnesium sulfate and the solvent removed.  
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Results and Discussion 
 
Figure 1 shows the overall scheme of the proposed synthesis of titananthracene.  Each step that 
was accomplished will be discussed in detail below.  It is thought that the stability of the 
titananthracene compound may be attributed to the delocalized π electrons present in its ring 
structure. 
Figure 2 
 
At this point of the study, the first three steps towards the synthesis of the titananthracene 
have been successfully carried out.  
 
Step 1:  
O
H
Br
O
OH
Br
Br
KCN
EtOH
105o C  
 
The formation of dibromobenzoin (2 in Figure 2) was successful each time the experiment was 
performed. Proton NMR spectroscopy clearly shows the presence of the product at about 6.2 
ppm (Figure 3). The reaction gave a 50% yield of an oily product.  
 
Step 2: 
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O
OH
Br
Br
HO COOH
Br
Br
KBrO3 , KOH
H2O, reflux
85 - 90o C
 
 
 
This reaction produced solid yellowish-white crystals (3 in Figure 2) and gave about 40% yield. 
Infrared spectroscopy showed a broad peak at 3400 cm-1 and a sharp peak at 1700 cm-1 
indicating the presence of both an –OH and a –COOH group. NMR spectroscopy showed a 
broad –OH peak at a range of 1-2 ppm and a –COOH peak at 10.2 ppm (Figure 4).  
 
Step 3:  
HO COOH
Br
Br
Na3BiO4
H3PO4
O
Br
Br  
 
 
The above reaction gave a dark red colored product. However, contrary to previous publications 
the compound 2,2’- Dibromobenzophenone (4 in Figure 2) was produced in extremely low 
yields. Although, the NMR analysis (Figure 5) shows the presence of the desired product, the 
concentration is too insignificant to carry out the next step. This reaction has not given a high 
yield of product up to this point.  
 
 
 
 
 
10 9 8 7 6 5 4 3 2 1 0 ppm
678910 ppm
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Figure 3: 1H NMR spectrum for 2,2’-Dibromobenzoin. 
10 9 8 7 6 5 4 3 2 1 0 ppm
-111 10 9 8 7 6 5 4 3 2 1 0 ppm
 
Figure 4: NMR spectrum for product 2, 2,2’ – Dibromobenzilic acid 
10 9 8 7 6 5 4 3 2 1 0 ppm  
Figure 5: NMR spectrum for product 3, 2,2’ – Dibromobenzophenone.  
Conclusion 
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The overall scheme of the proposal seems to be favorable towards the production of 
titananthracene. The TMS group is expected to eliminate the problem of removing the hydride 
from the dibenzometallacyclohexa-2,5-dienes. The successful preparation of titananthracene will 
be useful in future research of metallabenzenes and contribute significantly towards the study of 
metallaromatics.  
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Understanding the Mechanism of Trichloroacetic Acid-Induced Precipitation 
of Proteins 
Charles Loftis, Langston University 
Langston, Oklahoma 
 
 
Abstract 
The mechanism of 2,2,2-trichloroacetic acid (TCA)- induced precipitation of proteins is 
examined. The TCA- induced protein precipitation curves are observed to be U- shaped 
and does not significantly depend on the nature and size of the protein. It is observed that 
the protein-precipitate-inducing effect of TCA is mainly due to the trichloro group in the 
molecule. In this study, using acidic fibroblast growth factor (aFGF), we attempt to 
understand the molecular mechanism underlying the TCA-induced protein precipitation 
by using a variety of biophysical techniques including multidimensional NMR 
spectroscopy. We show that in the sodium trichloro acetate (STCA) is a protein denaturant 
even at neutral pH. The unfolding of aFGF in STCA is shown to involve the formation of a 
stable equilibrium intermediate. 1-anilino-8-napthalene sulfonate (ANS) binding and size-
exclusion chromatography results suggest that aFGF exist as a partially structured state(s) 
in 5 % (w/v) STCA. Limited trypsin digestion analysis and urea-induced unfolding (in 
presence of 5 % STCA) data reveal the flexibility in portions of the protein backbone is 
increased in the partially structured state(s) of aFGF in 5 % (w/v) STCA. Chemical shift 
perturbation monitored by 1H-15N heteronuclear single quantum coherence spectra reveals 
that profound structural changes in the intermediate state [in 5 % (w/v) STCA] occur in 
the C-terminal and N-terminal regions of the aFGF molecule. The results collectively 
suggest that TCA-induced protein precipitation is mostly due to reversible association of 
protein molecule in their “molten globule (MG)” -like state(s). 
Abbreviations 
 
TCA- 2,2,2-Trichloroacetic acid; ANS- 1-Anilino-8-napthalene sulfonate; STCA –Sodium 
trichloroacetate; SDS-PAGE- sodium dodecyl sulfate polyacrylamide gel electrophoresis; 
HSQC-Heteronuclear Single Quantum Coherence; CD- Circular Dichroism; FGF-Fibroblast 
Growth Factor; NMR-Nuclear Magnetic Resonance. 
 
Introduction 
Protein folding is a process in which an unfolded polypeptide chain of a natural protein 
folds into a specific native structure with associated biological activity (1). Because of large 
number of possible conformations available for a given protein, it has to go through a sequence 
of intermediates to fold into it native structure (2). So identification and characterization of 
“molten globule (MG)”- like partially structured intermediate states could help to understand the 
proteins in their organizational level (3). The molten globule (MG) state is a well-known 
example of a partially folded equilibrium state (4-7). MG states have been proposed to be 
involved in a number of physiological processes, such as protein recognition by chaperones, 
release of protein ligands, protein translocation across bio-membranes and protein aggregation 
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(8). Protein aggregation is a widespread phenomenon that occurs during protein folding in vivo 
and in vitro (9). The formation of aggregates is considered to be a non-specific association of 
partially folded intermediate state(s) through their exposed hydrophobic interactions to form 
precipitate (10). Understanding the mechanism of protein aggregation is important in solving the 
problem of formation of inclusion bodies during overexpression of recombinant protein in host 
vectors and also in the prevention and cure of various human diseases (including Alzheimer's 
disease) (11). 2,2,2-trichloroacetic acid (TCA) is a well-known protein precipitating agent (12). 
In the present study, we attempt to understand the mechanism by which TCA induces 
precipitation of proteins, using various biophysical techniques including multidimensional NMR 
spectroscopy.  
Materials and Methods 
 
Ingredients for Luria Broth were obtained from AMRESCO. Hen egg- whote lysozyme, 
TCA, acetic acid, monochlroacetic acid dichloroacetic acid, trichloroacetic acid, tribromoacetic 
acid, hydrochloric acid, perchloroacetic acid, trypsin, Aprotinin, pepstatin, leupeptin, 
phenylmethylsulfonyl fluoride, Triton X-100, and β-mercaptoethanol were obtained from Sigma 
Co. (St. Louis). Heparin-sepharose was obtained from Amersham Pharmacia Biotech. Labeled 
15NH4Cl and D2O were purchased from Cambridge Isotope Laboratories. All other chemicals 
used were of high quality analytical grade. All experiments were performed at 25 C. Unless 
specified, all solutions were made in 10 mM phosphate buffer (pH 7.0) containing 100 mM 
NaCl.  
Expression and purification of aFGF.  Recombinant aFGF was prepared from transformed 
Escherichia coli BL21(DE3)pLysS. The expressed proteins were purified on a heparin-sepharose 
affinity column over a NaCl gradient (0-1.5 M). Desalting of the purified protein was achieved by 
ultrafiltration using an Amicon set-up. The purity of the protein was assessed using SDS-PAGE. 
The authenticity of the truncated sample was verified by ES-Mass analysis. The concentration of 
the protein was estimated based on its extinction coefficient value at 280 nm. 
Preparation of isotope-enriched aFGF. Uniform 15N labeled aFGF were achieved using M9 
minimal medium containing 15NH4Cl. In order to realize maximal expression yields, the 
composition of the M9 medium was modified by the addition of a mixture of vitamins. The 
expression host strain E. coli BL21(DE3)pLysS is a vitamin B1-deficient host and hence the 
medium was supplemented with thiamine (vitamin B1). Protein expression yields were in the 
range of 25-30 mg/liter of the isotope-enriched medium. The extent of 15N labeling was verified 
by ES-Mass analysis (13).  
Treatment with acids. The proteins, aFGF, lysozyme, and BSA were treated with TCA and other 
acids by the method of sagar et al., (14). Protein solutions containing appropriate concentration 
of the respective acids were prepared by the addition of requisite amounts of the stock solutions 
of the individual acids to aqueous solutions of proteins. The acid(s) treated proteins solutions 
were incubated at 25 °C for 1 hr. The precipitated proteins samples were pelleted down by 
centrifugation at 12, 000 rpm for 20 mins. The precipitated products of the reaction were 
analyzed by SDS-PAGE.  Protein concentrations in the supernatant were determined using the 
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respective molar extinction coefficients of the proteins at 280 nm. All the UV spectrophotometric 
measurements were carried out on a Hitachi-3300 spectrophotometer.  
Steady-State Fluorescence Measurements. All fluorescence spectra were collected on a Hitachi 
F-2500 spectrofluorometer at 2.5 nm resolution, using an excitation wavelength of 280 nm. 
Fluorescence measurements were made at a protein concentration of 0.5 mg/mL in 10 mM 
phosphate buffer containing 100 mM NaCl. Blank corrections were made in all of the spectra 
using 10 mM sodium phosphate containing 100 mM NaCl.  
ANS Binding Experiments. The 1-anilino-8-naphthalene-sulfonate (ANS) binding experiments 
at various percentage of STCA (w/v) were performed using a Hitachi F-2500 spectrofluorimeter 
at 25 C. Fluorescence spectra were acquired using an excitation wavelength of 390 nm and an 
emission wavelength of 400-600 nm. All protein samples were prepared in 10 mM phosphate 
buffer (pH 7.0) containing 100 mM NaCl. Final spectra were obtained after correcting for the 
background fluorescence of ANS.  
Urea-Induced Unfolding. Urea-induced equilibrium unfolding, under various conditions, was 
monitored by intrinsic tryptophan fluorescence. For the unfolding experiments, protein samples 
were dissolved in appropriate concentrations of urea prepared in 10 mM phosphate buffer (pH 
7.0) containing 100 mM NaCl. Necessary background corrections were made in all the spectra.  
STCA-Induced Denaturation. The acid-induced denaturation experiments were monitored by 
fluorescence (Hitachi F-2500 spectrofluorometer) and far-UV CD (at 228 nm) spectroscopy 
(AVIV-215 spectropolarimeter) at 25 C. Protein samples were prepared in 10 mM sodium 
phosphate containing 100 mM NaCl. Blank corrections were made in all of the spectra using 10 
mM sodium phosphate buffer containing 100 mM NaCl.  
Circular Dichroism. All CD measurements were made on an AVIV-215 spectropolarimeter 
using a 1 mm path length quartz cell. Each spectrum was an average of 10 scans. The 
concentration of the protein used was 0.5 mg/mL (in 10 mM sodium phosphate containing 100 
mM NaCl). The final spectra were obtained after necessary blank corrections with 10 mM 
sodium phosphate containing 100 mM NaCl.  
Size-Exclusion Chromatography. All gel filtration experiments were carried out at various pH 
(at 25 C) on a superdex-75 column using an AKTA FPLC device (Amersham Pharmacia 
Biotech). The column was equilibrated with 2 bed volumes of the buffer (10 mM sodium 
phosphate containing 100 mM of NaCl) at the appropriate concentration of STCA (w/v). The 
flow rate of the eluent was set at 1 mL/min. Protein peaks were detected by their 280 nm 
absorbance. The concentration of the protein used was about 0.5 mg/ mL. 
Proteolytic Digestion Assay. Digestion experiments were carried out by independently 
incubating aFGF in the presence of 5 % (w/v) STCA with trypsin (at 1:1 protein to trypsin molar 
ratio) in 10 mM phosphate buffer containing 100 mM NaCl. The protease action was stopped by 
heating the mixture (protein + trypsin) at 90 C for 10 min. The products of the protease 
reaction were analyzed by SDS-PAGE analysis. The degree of cleavage was measured by 
estimating the intensity of the band (on SDS-PAGE) corresponding to aFGF and the C2A 
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domain (remaining after trypsin digestion) using a scanning densitometer. The intensity of the 
bands corresponding to the untreated aFGF was considered as a control for 100% protection 
against trypsin action. 
 NMR Experiments. All NMR experiments were performed on a Bruker Avance-700 MHz NMR 
spectrometer equipped with a cryoprobe at 25 C. 15N decoupling during data acquisition was 
accomplished using the globally optimized altering phase rectangular pulse sequence, and 2048 
complex data points were collected in the 15N dimension. 1H-15N HSQC spectra were recorded at 
64 scans at different pH values. The concentration of the protein sample used was 0.1 mM in 
90% H2O and 10% D2O (10 mM sodium phosphate containing 100 mM NaCl). The spectra 
were processed on a Windows workstation using Xwin-NMR and Sparky software (15). 
Results and Discussion 
TCA-induced protein precipitation.  In the present study, we investigate the chemical and 
physical basis of the TCA-induced protein precipitation. Trichloroacetic acid has been routinely 
used as a protein-precipitating agent. We studied the action of TCA over a wide range of 
concentrations (0-90 % w/v) on four different proteins; namely lysozyme, BSA, carbonic 
anhydrase and aFGF (Fig. 1A). BSA is an acidic proteins (pI= 5.60), while lysozyme is basic 
protein with pI of 9.12. The pI of carbonic anhydrase is in the neutral pH range (pI= 6.6). As the 
shapes of the protein precipitation curves (Fig. 1B) of all the four proteins are similar (U-
shaped), it appears that the protein-precipitating action of TCA is mostly independent of the 
nature of the protein(s) used. In general, the action of TCA on all the proteins used can be 
classified to occur in three states as shown in Fig.1B. In the first phase, occurring below 5 % 
(w/v), most of the protein is found in solution. However, in phase 2, occurring between 5 to 45 % 
(w/v) TCA concentrations, most of the protein precipitates. When the acid concentrations are 
raised above 50 % (phase 3), all the proteins is found in solution (Fig. 1B). The differential 
action of TCA in terms of protein precipitation at various concentrations indicates that acid-
induced structural transitions occur in the proteins. At this juncture, there are three questions 
arise. First, what physical-chemical properties of TCA are responsible for its protein-
precipitating action? And second, whether TCA is efficient to precipitate the partially structured 
and denatured state(s) of the proteins? And third,what structural transitions does TCA induce in 
the protein which renders the protein precipitation-competent? In the present study, we address 
all these questions and we believe that answers should help in the understanding the molecular 
mechanism for the TCA-induced protein precipitation.  
TCA-induced precipitation of denatured protein. Unfolding of lysozyme monitored by steady 
state fluorescence reveals that the protein is completely unfolded beyond 6 M urea (Fig. 2A). 
Figure 2B shows the precipitation profile of lysozyme in presence of increasing concentrations 
of urea from 0 M to 7 M urea. The Cm (concentration of the denaturant at which 50 % of the 
protein is unfolded) values of unfolding curves obtained from the fluorescence experiment is ~ 
3.8 M. We used SDS-PAGE analysis to study the action of TCA over a wide range of 
concentrations (0-90 % w/v) in the lysozyme in presence of increasing concentrations of urea (0-
7 M) (Fig. 2B). The intensity of protein band at ` 15 kDa (after Coomassie Blue staining) is used 
as a control to monitor the degree of precipitation at different concentrations of urea. The 
percentage of protein precipitated gradually decreased as the urea concentration gets increased 
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(Fig. 2C). These results reveal that the TCA- induced precipitation in the denatured state(s) is 
significantly less efficient than in the native state of the protein. 
Effect of trichloro group on protein precipitation.  In order to understand the chemical property 
of the TCA, we investigated the protein precipitation by various acids including, dichloroacetic 
acid (DCA), monochloroacetic acid (MCA), tribromoacetic acid (TBA), trifluoroacetic acid 
(TFA), perchloric acid (PC), hydrochloric acid (HCl), acetic acid (AC), and sodium 
trichloroacetate (STCA) (Fig. 3A). Acetic acid, monochloroacetic acid and hydrochloric acid are 
mostly unable to induce precipitation of protein (Fig. 3B). However dichloroacetic acid, 
tribromoacetic acid and trifluoroacetic acid induce precipitation of lysozyme only to some extent 
(Fig. 3B). The results of these experiments show that the presence of three chloro groups (on the 
alpha carbon atom) in the acetic acid molecule is important for the protein-precipitating action. It 
may be argued that the protein precipitation could be a pH-dependent effect, because the increase 
in the number of electronegative chloro groups effectively increases the acidity of the acid. 
However, HCl (a stronger acid than TCA) is unable to induce protein precipitation even up to 90 
% (w/v) (Fig. 3B). Trifluoroacetic acid (TFA), which is a stronger acid than TCA and possess 
three-fluoro group, is not more efficient than TCA. The maximum protein precipitation noticed 
with TFA was only around 15-20 % (w/v) (Fig. 3B). After higher concentrations (> 20 %), TFA 
starts cleaving the protein to small fragments (Fig. 3A). Comparison of these results clearly 
implies that acid-induced protein precipitation is unique to TCA and appears that the trichloro 
group is important for protein precipitation.  
Characterization of “molten globule”- like state. The molecular basis of the TCA-induced 
protein precipitation could be best understood by studying the structural change(s) occurring in 
the protein upon addition of sodium trichloro acetate (STCA).  Hence, we decided to investigate 
the STCA-induced structural transitions in aFGF. aFGF is a 16 kDa , all β-sheet  protein that is 
involved in a wide array of cellular processes regulating cell proliferation (16). aFGF is devoid 
of disulfide bonds and possesses a single tryptophan residue, which could be effectively used as 
a probe to monitor the conformational changes occurring in the protein under various physical 
conditions (17). The secondary structural elements in the protein include 12 β- strands arranged 
antiparalley into a β-barrel structure (16).  
STCA-induced Unfolding of aFGF. The fluorescence spectrum of aFGF is dominated by 
tyrosine emission at 308 nm (17). The emission of the lone tryptophan emission at position 121 
is quenched by the presence of proximate positive charges in the three-dimensional structure of 
the protein. This quenching effect is completely relieved in the unfolded state of the protein, and 
the characteristic tryptophan emission is observed at 350 nm. These structural features are ideal 
to monitor the conformational changes induced in the protein during the unfolding process.  
 Unfolding of aFGF monitored by steady state fluorescence reveals that the protein is 
completely unfolded beyond 10 %  (w/v) STCA (Fig. 4A). For increasing concentration of 
STCA an initial sharp increase (in the ration of 350 over 308 nm was observed) was observed at 
10 %  (w/v) STCA. A further increase in STCA concentration up to 90 % (w/v) resulted in a 
decrease in the fluorescence (in the ration of   350 over 308 nm). Increasing of STCA 
concentration the fluorescence emission intensity decreased markedly, showing that STCA may 
quench the fluorescene (Fig. 4A-inset). This phenomenon can be interpreted as follows. At lower 
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concentrations of STCA (<10 %), STCA causes unfolding of aFGF as a result of an increase in 
the electrostatic repulsion between the polypeptide side chains. In contrast, at higher STCA 
concentrations (>10 %) may result in complete unfolding of the protein.  
Circular Dichroism Spectra. CD spectra in the far UV region (Fig. 4B-inset) show changes in 
the secondary structure of treatment with various concentration of STCA.  The STCA-induced 
unfolding process probed by the ellipticity changes at 228 nm (a composite CD signal 
contributed by the secondary structural elements and optical active aromatic groups in the 
protein). aFGF samples subjected to the treatment of up to 90 % (w/v) STCA showed decrease in 
ellipticity. However, while aFGF was denatured in higher concentrations of STCA [> 10 % 
(w/v)], the peak at 228 nm disappeared, and the conformational change suggests that STCA is 
likely to induce the formation of a random coil (Fig, 4 B). Below 5 % (w/v) STCA concentration, 
the solution containing aFGF remains clear. The CD spectra of aFGF in 1 % (w/v) STCA 
showed that no significant structural change(s) occurred in the protein. These results from 
fluorescence and CD experiments with aFGF clearly show the structural transitions occurred in 
presence of STCA.   
STCA induce a “molten-globule”-like structure on aFGF. ANS is a fluorescent dye that binds 
to hydrophobic regions of proteins (18). This fluorescent probe has been useful in the 
identification of equilibrium intermediates such as the MGs. Molten globule intermediates 
usually displays a significant exposure of hydrophobic cores to the solvent. Hence, ANS binds 
strongly to MG states and fluorescence intensely (18, 19). The dye generally exhibits weak 
binding affinity to the native and unfolded states of proteins (18). The binding affinity of aFGF 
to ANS at various concentrations of STCA was monitored by the changes in the emission 
intensity at 520 nm (Fig.5A). The emission intensity of ANS upon binding to protein (aFGF) in 5 
% (w/v) STCA is more than twice that observed with the protein in its native state (Fig. 5A). 
Fluorescence spectra of ANS in the presence of the protein in 5 % (w/v) STCA reveals that the 
emission maxima of the dye blue shifts by about 10 nm. Further increase in the concentration of 
STCA results not only in the progressive decrease in the emission intensity but also is 
accompanied by a continuous red shift in the emission maxima. The protein in its unfolded 
conformation(s) and beyond 10 % STCA exhibits weak binding to ANS (Fig. 5A). The results of 
ANS binding experiments clearly suggest that aFGF exists in a partially structured “molten 
globule”-like intermediate state with greater exposure of hydrophobic sites as compared to the 
native and denatured protein.  
Size-exclusion chromatography (SEC) is a useful technique for obtaining information on 
the conformational changes that occur during the unfolding of the protein (20).  SEC is an inert 
technique that does not perturb the equilibrium between the native, intermediate, and denatured 
states of proteins (20). Therefore, we monitored the relative population of the various molecular 
states of aFGF that may exist under various STCA concentrations. aFGF, in its native state (at 
pH 7.0), elutes as a single peak with an elution time of 85 ± 0.5 min (Fig. 5B-a). aFGF in the 
denatured state(s), in 50 % (w/v) STCA, also elutes as a single peak at 48 ± 0.5 min (Fig. 6A-c). 
The SEC elution profile of aFGF in 5 % (w/v) STCA shows two closely eluting peaks at 61 ± 0.5 
and 64 ± 0.4 min. These closely eluted peaks possibly represent the population of molecules in 
the compact, partially unfolded states (Fig. 5B-b). Peaks representing the native (elution time, 85 
± 0.5 min) and denatured states (elution time, 482 ± 0.5 min) of aFGF were completely absent in 
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the elution profile obtained at 5 % (w/v) STCA (Fig. 5B-b). It is surprising to find that the 
elution times of the peaks representing the partially unfolded states of aFGF (at 5 % (w/v) 
STCA) are longer than that observed for the denatured states in 50 % (w/v) STCA. It is not 
reasonable to conceive that the observed longer elution times are due to the highly compact 
nature of the partially unfolded states of the protein. The results of the SEC experiment clearly 
show that the STCA unfolding of aFGF proceeds via the accumulation of a stable partially 
structured intermediate state(s). Thus, results of the ANS binding and the SEC experiments 
analyzed in conjunction, clearly suggest a MG-like intermediate state(s) maximally accumulates 
at 5 % (w/v) STCA.  
The Intermediate state has higher conformational flexibility. Proteins in the MG state(s) are 
proposed to have considerable native secondary structural interactions and greater flexibility of 
the side chains because of loss in some tertiary structural interactions (21). Limited proteolytic 
digestion is an immensely useful technique to probe the gross conformational flexibility of 
proteins (22). In general, proteolytic digestion is governed not only by the stereochemistry and 
accessibility of the protein substrate but also by the specificity of the proteolytic enzyme. 
Therefore, subtle conformational changes that occur in a protein during equilibrium 
unfolding/refolding can be easily monitored by the limited proteolytic digestion technique. 
Because aFGF is rich in arginine and lysine residues, we opted to perform a limited trypsin 
digestion to probe the conformational flexibility of the proteins in their native state as well as the 
partially unfolded states that accumulate in 5 % STCA. Time-dependent trypsin digestion of the 
proteins in their native (at pH 7.0) and partially unfolded (in 5 % STCA) states was monitored by 
SDS-PAGE analysis. The SDS-PAGE shows the degree of proteolytic cleavage clearly shows 
that aFGF exists in a partially unfolded state at 5 % (w/v) STCA (Fig. 6A). Undigested aFGF 
yields a band on SDS-PAGE, which corresponds to a molecular mass of about 16 kDa (Fig. 6A). 
The intensity of this band (after Coomassie Blue Staining) is used as a control to monitor the 
degree of action of trypsin on the native and the intermediate state(s) of aFGF. After 10 min of 
incubation, aFGF (in its native state) with trypsin leaves about 40 % of the protein uncleaved. In 
the partially unfolded state, band representing the intact aFGF molecule completely disappears 
within 5 min of incubation with trypsin (Fig. 6A). These results reveal that the protein in the 
intermediate state as compared with the native state is more susceptible to proteolysis implying 
increased conformational flexibility of the protein in the intermediate state(s) observed in 5 % 
(w/v) STCA. 
Stability of aFGF under 5 % STCA conditions. Urea-induced equilibrium unfolding of aFGF as 
monitored by steady-state fluorescence. The urea-induced unfolding profile of aFGF at 5 % 
(w/v) STCA (‘MG”- like state) by changes in the fluorescence intensity at 350 nm, shows that 
the protein is denatured completely in urea concentrations greater than 1.2 ± 0.02 M urea (Fig. 
6B). It may be of interest to note that the urea-induced equilibrium folding of aFGF (in native 
state) at pH 7.0 shows that the protein is denatured completely in urea concentration greater than 
3.0 ± 0.02 M (Fig. 6B). These results clearly shows that the protein in the “MG’-like state is 
significantly less stable than the native state. 
Perturbed regions in the partially unfolded states. The 1H-15N HSQC spectrum serves as a 
fingerprint of the backbone conformation of a protein under given experimental conditions (23). 
1H-15N HSQC of aFGF in its native state (0 %  (w/v) STCA) is well-dispersed, indicating that the 
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protein is well-structured (Fig. 8A). All the cross-peaks in the HSQC spectrum of aFGF have 
been previously assigned, and therefore, it is convenient to monitor the structural changes that 
occur as a function of increasing concentrations of STCA. Many cross-peaks show significant 
chemical shift perturbation and also disappear in the 1H-15N HSQC spectrum of the aFGF 
acquired in 5 % (w/v) STCA (Fig. 7A). In general, the decrease in cross-peak intensity of 
selective residues is ascribed to faster internal mobilities of residues in the flexible regions of the 
protein molecule. Cross-peaks corresponding to Cys30, His35, Ile56, Leu86, Asn114, Lys115, 
Trp121, Phe122, Lys126, Lys132, Gly134, and Tyr139 completely disappeared in the 1H-15N 
HSQC spectrum of aFGF obtained in 5 % (w/v) STCA (Fig. 7B). Cross-peaks of some other 
residues corresponding to Leu28, Tyr29, Val45, Ser72, Meth81, Leu98, Lys115, Trp121, 
Lys126, Lys132, Gln141, Ala143, Ile144, Leu145, Phe146, Lys148 and Leu149 in the HSQC 
spectrum also show a dramatic 1H-15N chemical shift perturbation (Fig 7C). These residues are 
mostly located in β-strand I, β-strand II, β-strand VIII, and the loop connecting β-strands VIII 
and IX, and β-strand XI (Figure 7D). The HSQC spectra of aFGF acquired beyond 10 % (w/v) 
STCA show limited chemical shift dispersion and are typical for an unfolded protein (date not 
shown). From the results discussed above, it is reasonably clear that the many structural 
interactions stabilizing the native state are largely disrupted in the partially unfolded states of 
aFGF. 
In this paper, a systematic study was only carried out on aFGF, we believe that that 
phenomenon reported here also operates in the case of TCA-induced precipitation of other 
proteins. We also found that the 5 %(w/v) STCA-treated aFGF samples when left for several 
days turn turbid and eventually precipitate. Thus, we believe that the “MG”-like state in 5 % 
(w/v) STCA should possess structural features very similar to the partially structured 
intermediate state (s), which is actually involved in the instantaneous precipitation. However at 
high concentration of TCA (> 50 %) proteins fail to precipitate because the protein molecules 
directly go into unfolded state. But in other acids like HCl and AA unfolding does not form any 
stable intermediate(s), this may be the reason as to why protein does not precipitate.   
 In this paper, we demonstrate that TCA-induced protein precipitation is independent of 
the size and nature of the proteins, TCA-induced precipitation in the denatured state(s) is 
significantly less efficient than in the native state. The trichloro moiety present in the TCA is 
important for its protein precipitation capability. Using aFGF, we also demonstrate that TCA-
induced protein precipitation occurs largely due to reversible association of partially structured 
state(s) of the protein. 
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Legends to Figures 
 
Figure 1: A- SDS-PAGE analysis SDS-PAGE analysis of the TCA-induced precipitation of 
lysozyme, BSA, Carbonic anhydrase, and aFGF. Lane: M-Marker, 1- 0% TCA, 2- 5% TCA, 3- 
10% TCA, 4- 15% TCA, 5- 20% TCA, 6- 25% TCA, 7- 30% TCA, 8- 35% TCA, 9- 40% TCA, 
10- 45% TCA, 11- 50% TCA, 12- 55% TCA, 13- 60% TCA, 14- 65% TCA, 15- 70% TCA, 16- 
75% TCA, 17- 80% TCA, 18- 85% TCA, and 19- 90% TCA (w/v) respectively. B-The 
percentage of TCA-induced protein precipitation of lysozyme (closed circle), BSA (open circle), 
carbonic anhydrase (x), and aFGF (open square) were measured based on the intensity (after 
Coomoassie blue staining) of the bands of the corresponding proteins (on the polyacrylamide 
gel).  
Figure 2: A- Fraction of unfolded species of the lysozyme formed at various concentrations of 
urea.The unfolding profile was monitored by the changes in the emission intensity at 340 nm . 
The Cm value for the urea-induced unfolding of the aFGF estimated from the fluorescence 
experiments is 4.0 ± 0.05 M. B- SDS-PAGE analysis SDS-PAGE analysis of the TCA-induced 
precipitation of lysozyme. Lane: M-Marker, 1- 0% TCA, 2- 5% TCA, 3- 10% TCA, 4- 15% 
TCA, 5- 20% TCA, 6- 25% TCA, 7- 30% TCA, 8- 35% TCA, 9- 40% TCA, 10- 45% TCA, 11- 
50% TCA, 12- 55% TCA, 13- 60% TCA, 14- 65% TCA, 15- 70% TCA, 16- 75% TCA, 17- 80% 
TCA, 18- 85% TCA, and 19- 90% TCA (w/v) respectively. C- The percentage of protein 
precipitated in the presence of different concentrations of urea, 0 M urea- open circle, 1 M urea- 
closed circle, 2 M urea- open triangle, 3 M urea- x, 4 M urea- -+, 5 M urea- (open triangle-
upside), 6 M urea (open triangle-open triangle- downside), and 7 M urea- opne square, was 
measured based on the intensity (after Coomoassie blue staining) of the ~15-kDa protein band 
(on the polyacrylamide gel).  
Figure 3: A- SDS-PAGE analysis of the precipitation of lysozyme induced by different acids. 
Lane: M-Marker, 1- 0%, 2- 5%, 3- 10%, 4- 15%, 5- 20%, 6- 25%, 7- 30%, 8- 35%, 9- 40%, 10- 
45%, 11- 50%, 12- 55%, 13- 60%, 14- 65%, 15- 70%, 16- 75%, 17- 80%, 18- 85%, and 19- 90% 
(w/v). B- The percentage of protein precipitated in TCA- open cirlcle, dichloroacetic acid – 
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closed circle, monochloroacetic acid- open triangle, tribromoacetic acid- x, trifluoroacetic acid - 
+, perchloric acid- open triangle -upside, hydrochloric acid –open square, and acetic acid- open 
triangle down side was measured based on the intensity (after Coomoassie blue staining) of the 
~15-kDa protein band (on the polyacrylamide gel).  
Figure 4: A- Changes in the structural properties of aFGF as a function of increasing 
concentration of STCA monitored by relative fluorescence. STCA appears to induce 
denaturation of the protein at neutral pH. The inset shows the emission spectra of the aFGF at 
different concentration of STCA. a- 0 % STCA, b- 5 % STCA, and c- 50 % STCA (w/v). B- Plot 
of ellipticity at 228 nm for aFGF treated with varying concentrations of STCA. The inset shows 
the far- UV CD spectra of the aFGF at different concentration of STCA. a- 0 % STCA, b- 5 % 
STCA (w/v), and c- 50 % STCA (w/v).  
Figure 5: A- Binding of ANS to aFGF at various concentrations of STCA. Change in intensity at 
520 nm (closed circle) and the shift in wavelength maximum on ANS binding (open square) are 
shown. The inset shows the emission spectra of the aFGF at different concentrations of STCA. a- 
0 % STCA, b- 5 % STCA, and c- 50 % STCA (w/v). B- Size exclusion chromatography of 
aFGF, a- in the native, b- in the “MG”-like state in 5 % (w/v) STCA, and c- in the denatured 
state(s) in 50 % (w/v) STCA. Elution of the protein was monitored by its absorbance at 280 nm. 
The flow rate of elution was 1 mL/min. The concentration of the proteins used in the experiment 
was ~ 0.5 mg/ mL. Elution (at 25 C) was carried out using 10 mM phosphate buffer containing 
100 mM NaCl. 
Figure 6: A- SDS-PAGE analysis of the limited trypsin digestion products of aFGF in the native 
and in the “MG”- like state(s) in 5 % (w/v) STCA. Lane M shows the molecular weight marker. 
The lane marked as native represents the trypsin digestion products after various time periods of 
incubation of native aFGF with trypsin.  The lane marked as 5 % (w/v) STCA represents the 
trypsin digestion products after various time periods of incubation of “MG”-like state of aFGF in 
5 % (w/v) STCA. B- Urea-induced equilibrium unfolding profile of aFGF, native state (closed 
circle) and in “MG”- like state in 5 % (w/v) of STCA. 
Figure 7: A- Overlap of 1H-15N HSQC spectrum of aFGF in absence (red) and presence of 5 % 
(w/v) STCA (green). B- 1H-15N chemical shift perturbation of residues in aFGF in the presence 
of STCA [5 %(w/v)]. The amino acid residues in aFGF that showed significant chemical shift 
perturbation and involved in STCA binding are indicated by their single letter codes. C- Cross-
peak intensity of residues in the 1H-15N HSQC spectrum of aFGF obtained in the presence of 5 
% (w/v) STCA. The cross-peaks that show significant decrease in their intensities represent the 
STCA binding sites. D- MolMol representation of the structure of aFGF (grey). Residues that 
show significant decrease in intensity and chemical shift perturbation in presence of 5 % (w/v) 
STCA are depicted in green. 
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Protein Oxidation and its Applications in Probing Solvent Accessible Surface Residues 
Carrie Peter, John Brown University 
Siloam Springs, Arkansas 
 
Background 
 
Studies have shown that the amount of oxidized proteins in the human body increases with 
age and can be associated with diseases such as emphysema, cataracts, diabetes, chronic 
inflammatory diseases, cancer and many more (1, 2, 3). Oxidation of a protein generally occurs 
when the protein reacts with a reactive oxygen species (ROS). An ROS is a free radical; a 
compound that has an unpaired electron and is thus extremely reactive. One free radical 
compound can often result in the formation of other free radical compounds by reacting with a 
neighboring molecule using the following mechanisms (3). 
 
A. + B=C  A-B + C.  
A.-B-C  A. + B=C 
A. + B-  B. + A-                     
As a result of this behavior, free radicals remain in body and can cause significant damage to 
biologically important molecules such as proteins and lipids. Common ROS compounds are O2-, 
HO2., H2O2 (decomposes into O.H + OH-), and OH.. These can be produced in the body by 
cigarette smoke, fatty foods, pollutants, ozone, alcohol, and natural electron leakages from the 
electron transport chain in the mitochondria (1, 3). Free radicals can react with either the 
backbone of the protein which causes the protein to break apart, or it can react with the side 
chains of the proteins. When oxidation of a side chain occurs the secondary and tertiary structure 
of the protein will alter thus impairing the protein’s ability to function normally. A carbonyl 
product is often the result of protein oxidation and thus the number of carbonyls in a protein 
sample has become a common method for detecting oxidation (4). For example a common result 
for tryptophan oxidation is: 
 
    (5) 
 
 
 
The body does have ways to protect itself from these harmful reactions by using antioxidants. 
Antioxidants work by either capturing a free radical until the body is able to rid of it, or 
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enhancing the body’s own ability to find and discard of free radicals (3). Some antioxidants are 
even capable of doing both.   
Introduction 
 
The significant role protein oxidation plays in the body makes it an important research 
topic. Finding and understanding mechanisms by which proteins are oxidized would provide 
invaluable information to human health. Many research projects have already succeeded in 
oxidizing proteins in various ways. Often, hydroxyl radicals are produced using methods such as 
a synchrotron X-ray beamline or a metal catalyst with hydrogen peroxide (6). This summer Dr. 
Jack Lay’s research group hopes to find a simple and efficient method of oxidation and to 
determine the amount and locations of the oxidation by using the matrix assisted laser desorbtion 
time-of-flight mass spectrometry (MALDI-TOF-MS). To perform this, proteins are first oxidized 
and then digested with trypsin to obtain peptide mass fingerprint using MALDI-TOF-MS. By 
comparing the oxidized protein’s data to an un-oxidized (control) protein’s data, the tryptic 
peptide fragments where oxidation occurred can be easily detected. Both data sets should contain 
peaks at the same masses, but the oxidized protein should have additional peaks 16 Da greater 
than that of un-oxidized peaks; the addition of 16 Da indicates the addition of an oxygen atom on 
the protein. The method becomes more complicated when other oxidation reactions are taken 
into account besides simple the addition of oxygen and were ignored in this experimental study. 
For example, utilizing information from previous protein oxidation research we made a library of 
oxidized amino acids and the mass changes that occur upon oxidation (table 1). There are 
numerous possible mass shifts associated with multiple oxidation mechanisms and attempting to 
detect each on the peptide mass fingerprint would be difficult for our preliminary research. 
 
Amino Acid Reaction Mechanism Product Change in Weight (Da) 
Tyr HO.  Dopa 16 
Phe HO.  o-tyrosine 16 
Trp HO.  Kynurenine 4 
Trp Carbonyl formation Trp carbonyl 4 
Leu HO.  2-Oxohistidine -45.05 
Leu HO.  isovaleric acid -29 
Met Carbonyl formation Methionine Sulfoxide 16 
Met Carbonyl formation Methionine Sulfone 32 
His Carbonyl formation His carbonyl 14 
Tyr HOCl 3-Chlorotyrosine 34 
Table 1: Lists some of the possible mass changes that can occur when a given amino acid is oxidized (1,2).   
We first attempted to oxidize the protein bovine serum albumin (BSA) by adding small amounts 
of H2O2 to an aqueous solution of the protein or small amounts of bleach to an aqueous solution 
of the protein. Next, we experimented catalyzing the reaction using Fe (III). We used peptides 
and small proteins for these reactions so that the oxidation was easier to detect. Also, we used 
proteins of a known x-ray structure to determine of oxidation with the MALDI-TOF-MS is an 
appropriate method for protein mapping.     
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Experimental Procedures 
To oxidize the BSA one-hundred micro-liters of a stock solution of 1 mg/ml BSA in 
water was placed in a reaction vessel with 5 μL of either the bleach or H2O2 (30%). These 
samples as well as a sample of un-oxidized BSA (1 µg/ µL) were then digested with the protease 
trypsin by adding 25 µL of 20 ng/µL trypsin solution to 10 µL of the protein solution for a 20:1 
protein to trypsin ratio. The digestion was then allowed to sit over night in an incubator. Using   
1 dyhydrobenzoic acid (DHB) (prepared in 90% MeOH in 0.1% formic acid (FA)) as the 
MALDI matrix the samples were spotted on to a unpolished stainless steel MALDI target by 
mixing analyte to matrix in the ratio of 1:1.  Following standard protocol, MALDI-TOF mass 
spectrometer was calibrated before analyzing the sample. The peptide mass finger print obtained 
from the spectrometer was compared to expected tryptic fragment peaks using the software 
called “peptide mass” (in-silico protein digestion software) available in the EXPASY server. 
This can also be done using any protein identification software available to perform peptide mass 
finger printing such as MASCOT. Once the peaks for the un-oxidized BSA were identified, they 
were found on the oxidized BSA’s graph. The percent intensities (the intensity divided by the 
largest intensity in the graph) of the corresponding peaks on the oxidized and un-oxidized graphs 
were compared and we analyzed the oxidized BSA’s graph for a peak 16 Da higher than the un-
oxidized tryptic fragment mass. If the percent intensity of the un-oxidized had decreased upon 
oxidation and there was a peak 16 Da higher we could assume that oxidation had occurred on 
that tryptic fragment. To determine if the oxidation sights were consistent and the amount of 
oxidation sufficient, mixtures of the oxidized and un-oxidized BSA in 1:5 and 1:10 ratios were 
analyzed on the mass spectrometer. We hoped that the intensities of the peaks would vary 
accordingly with the ratios. 
Our next set of experiments consisted of determining a method of oxidation for peptides 
and proteins that are much smaller than BSA. BSA is a large protein with a molecular weight of 
66 kDa and has a complex structure that makes oxidizing the internal residues very difficult. 
Thus, we decided to attempt oxidizing two small peptides: Angiotensin II, and Bradykinin. Their 
sequences are: 
Bradykinin: Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg 
Angiotensin II: Asp-Arg-Val-Tyr-Ile-His-Pro-Phe  
By finding an efficient method for oxidizing these, we hoped to be able to move on to oxidizing 
more complex structures such as small proteins and eventually BSA. We used the same method 
for analyzing the MALDI-TOF-MS data as we did with the BSA to determine which tryptic 
fragments were oxidized. However, we catalyzed these oxidations with iron using a procedure 
similar to that prescribed by Joshua S. Sharp for oxidizing the protein apomyoglobin (6). First, a 
stock solution (stock solution 1) of 20 mM sodium ascorbate and 50 mM sodium phosphate was 
prepared. A second stock solution (stock solution 2) was made consisting of 6 µM FeCl3, 13 µM 
EDTA, and 50 mM sodium phosphate. The Sharp procedure called for NH4Fe(SO4)2 instead of 
FeCl3, but we hoped the Fe (III) would work the same regardless of the compound it was in. 
Then, 30% H2O2 was diluted to 3% and a 2 M Tris buffer solution was prepared. For the 
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oxidation reaction 5 µL of 1 mg/mL peptide stock solution, 2 µL of stock solution 1, 2 µL of 
stock solution 2, 2 µL 3% H2O2 and 9 µL of 0.1 M Na2HPO4 were mixed for a final volume of 
20 µL. The reaction was quenched by adding 20 µL of the 2 M tris at 0, 5, 10 minute and 2 hour 
intervals. These samples were spotted on the MALDI-TOF-MS target using a Millipore ZIP Tip 
to remove salts from our sample. The ZIP Tip was used using the manufacture’s protocol: 
washing away the salts with 0.1% formic acid and eluting the protein with 60% acetonitrile.  
The Fe catalyzed procedure was repeated except the second stock solution was remade 
replacing the FeCl3 with NH4Fe(SO4)2 and fixing both stock solutions to a pH of 6.5 and the 
Tris solution to a pH of 5 by adding HCl or NaOH accordingly.  
To determine if the Fe (III) made a significant difference in the time of oxidation for the 
peptide we also oxidized each peptide using only H2O2. Five micro-liters of peptide were mixed 
with 3% H2O2, and 13 µL of H2O for a total volume of 20 µL and a 0.3% H2O2 concentration as 
it was in the Fe (III) catalyzed reaction. 
 For our final set of experiments we began to oxidize small proteins of a known x-ray 
structure. By doing this, we hoped to be able to determine if our method was appropriate for 
protein mapping. We choose to use Cytochrome C and Ubiquitin as our proteins. Again, we 
assumed that oxidation would cause a 16 Da increase in mass. Also, previous research has shown 
that cysteine and methionine are the amino acids most easily oxidized by the hydroxyl radical 
followed by phenylalanine, tyrosine, tryptophan, proline, histidine, then leucine (7). Using this 
information, we were able to focus our attention on the oxidation of these residues. First, 
undigested Ubiquitin was oxidized and quenched using the same procedure used on the peptides 
to ensure the oxidation would work. Then, we again oxidized Ubiquitin quenching it at 10 
minutes and 2 hours. The quenched protein was digested with trypsin. A control of un-oxidized 
Ubiquitin was also digested and ran on the MALDI-TOF-MS as well as a sample oxidized with 
H2O2 only, quenched at 2 hours and digested. By using the peaks found for the control and 
plugging them into EXPASY’s protein mass program we were able to see the amino acids in 
each fragment. By comparing the oxidized peaks to the un-oxidized as they were for BSA, the 
fragments that underwent oxidation were determined. Using the x-ray structure of the protein we 
could see which residues were on the surface and were thus able to be oxidized. Knowing this 
and knowing the residues that could be oxidized with our procedure we were able to determine 
which residue in the oxidized fragment was actually oxidized. Cytochrome C was tested in the 
same way as Ubiquitin.   
Data and Results 
 
Peptide mass finger print obtained for BSA oxidized using H2O2 was compared to that of 
un-oxidized revealed two possible oxidation sites. However, the intensities of these masses were 
very small even after allowing the H2O2 and protein solution to sit for two weeks (figures 1 and 
2). When the oxidized and un-oxidized protein was mixed in 1:5 and 1:10 ratios, we confirmed 
that the reaction was much weaker than what we hoped. When the un-oxidized and oxidized 
proteins were mixed, only the un-oxidized peaks were strong enough to be seen on the peptide  
mass fingerprint. 
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 Oxidizing the BSA with bleach was unsuccessful. The bleach was too strong of a reagent 
and probably destroyed the protein by cleaving back-bone of the protein instead of oxidizing its 
side chains. 
When Bradykinin and Angiotensin II were oxidized using FeCl3, the data obtained from 
the MALDI-TOF-MS did not show significant oxidation. When we switched to using 
NH4Fe(SO4)2 and changed the pH of stock solution 1 and 2, and the tris buffer, the results 
improved. The data for Bradykinin are in figure 3 and table 2 and the data for Angiotensin II in 
figure 4 and table 3. Both sets of results show a clear increase in the amount of oxidation as time 
progressed. 
Table 2: Shows the increase in the amount of oxidation on Bradykinin as the reaction was allowed to run longer. 
   0 min   5 min   10 min    2 hr   
  mass % Intens. mass % Intens. mass % Intens. mass % Intens. 
Bradykinin 1060.542 1.000 1060.566 1.000 1060.573 1.000 1060.840 1.000 
+1 O 1076.560 0.030 1076.615 0.076 1076.592 0.141 1076.849 0.540 
+2 O 1092.542 0.013 1092.592 0.035 1092.578 0.067 1092.854 0.400 
+3 O none   none   1110.579        0.017 1108.858 0.094 
Figure 1: The bottom graph shows 
BSA digested with trypsin and 
than oxidized with H2O2. The top 
graph shows BSA digested by 
trypsin only. The mass 1249.7 is 
for the fragment: 
FKDLGEEHFK. The peak at 
1255.7 possibly shows that 
fragment with His oxidized. 
However, the intensity is 
extremely low for the oxidized 
fragment which indicates the 
oxidation procedure was not 
effective.    
Figure 2: The bottom graph shows 
BSA digested with trypsin and 
than oxidized with H2O2. The top 
graph shows BSA digested by 
trypsin only. The mass 1439.9 is 
for the fragment: 
RHPEYVSVLLR The peak at 
1455.9 possibly shows that 
fragment with His oxidized. 
However, the intensity is 
extremely low for the oxidized 
fragment which indicates the 
oxidation procedure was not 
effective.    
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Table 3: Shows the increase in the amount of oxidation on Angiotensin II as the reaction is allowed to run longer. 
 
 
 
 
 
 
 
 
 
 
 
 
 0 min   5 min   10 min   
  mass % Intens. mass % Intens. mass % Intens. 
Angiotensin II  1046.467 1 1046.559 1 1046.573 1 
1 ox 1062.502 0.01304 1062.596 0.0934693 1062.607 0.124606 
2 ox  None   1078.5  0.058722 1078.599 0.0204 
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Based on the reactivity information from previous studies indicating cysteine, methionine are the 
most oxidizable, followed by phenylalanine, tyrosine, tryptophan, proline, histidine, then leucine, 
we determined the two phenylalanine residues most likely were oxidized within the first five 
minutes of the Braykinin oxidation. The third oxidation at 2 hours was most likely. We were not 
able to confirm these oxidation sites due to failures occurred to the couple mass spectrometers 
during my visit.  
 
The experiments that used H2O2 alone to oxidize the peptides worked much slower. By 
comparing the intensities of the Fe catalyzed reaction with the un-catalyzed reaction it is clear 
that more protein was oxidized within the 10 minute interval when the Fe catalyst was present.  
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figure 5 
 
To ensure our procedure would be effective with the Ubiquitin we oxidized and tested a 
sample without digesting it. The results showed that the Ubiquitin did undergo oxidation when 
Fe was present (Figure 6). Because of the large mass of the intact Ubiquitin, the results are not 
very sharp or precise.  
 
We then digested the Ubiquitin and obtained peptide mass fingerprints for both the 
oxidized and un-oxidized protein digestion (Figure 7). Using the EXPASY program we found 
the sequences and masses of the tryptic fragments of Ubiquitin (table 4). We then found each of 
the tryptic fragment peaks on our peptide mass fingerprint and looked for additional peaks in 
increments of 16 Da greater. The results of this experiment are described below table four. 
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Table 4 
    
            
 
 
 
 
 
MQIFVK: (1-6) showed the addition of 1 oxygen to the fragment at a mass of 781 Da for each of 
the experiments. According to past research either M or F can be oxidized. Looking at the 
structure of Ubiquitine both M and F are on the surface, but we assume M is the amino acid 
being oxidized because research has shown that it is more reactive. There was not any un-
oxidized fragments of MQIFVK detected in the samples that underwent the oxidation procedure 
indicating that all the fragments underwent oxidation. This led us to believe that the tris was not 
quenching the oxidation for methionine.  
 
TITLEVEPSDTIENVK: (12-27) showed no oxidation after 10 minutes with Fe, and showed 2 at 
2 hours with Fe at 1813 and 1819 Da. These oxidations probably occurred at the P and the first L 
which are accessible on the protein’s structure. There was no oxidation for the reaction without 
iron. 
 
IQDKEGIPPDQQR: (30-42) showed no oxidation at 10 minutes and 2 at 2 hours. Both P’s are 
accessible so we predict they are the oxidized residues. There was no oxidation for the reaction 
without iron.  
 
EGIPPDQQR: (34-42) is part of the above fragment that occurs with one missed cleavage. It 
confirmed the above result with 2 oxidations for the 2 hour reaction with iron. 
 
LIFAGK: (43-48) shows no oxidation in any of the experiments which agrees with our 
predictions because L not easily accessible on the protein and none of the other residues should 
oxidize. 
 
QLEDGR: (49-54) shows no oxidation in any of the experiment which confirms our predictions 
because L is not easily accessible on the protein and none of the other residues should oxidize. 
 
TLSDYNIQK: (55-63) showed no oxidation at 10 minutes and 1 oxidation at 2 hours. We 
apredict the Y was oxidized because it is easily accessible while both the L’s are buried. The 
reaction without iron showed no oxidation. 
 
m/z start  end Fragment sequence  
765.376 1 - 6 MQIFVK 
1787.846 12 - 27 TITLEVEPSDTIENVK 
1523.737 30 - 42 IQDKEGIPPDQQR 
1039.479 34 - 42 EGIPPDQQR 
648.328 43 - 48 LIFAGK 
717.277 49 - 54 QLEDGR 
1081.510 55 - 63 TLSDYNIQK 
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Because the first fragment (MQIFVK) showed complete oxidation in each reaction run 
we tested the hypothesis that the tris was not quenching the oxidation for methionine. To do this 
we took the peptide Substance P (sequence below) and oxidized using the same procedure except 
that the tris was added first. 
Substance P: Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met. 
We let the reaction sit for 5 and 10 minutes and then ran it on the MALDI. The results showed 
that oxidation still occurred. We did the same with Angiotensin II which does not contain a 
methionine. This peptide showed no oxidation showing us that our assumptions were correct.  
 The data for Cytochrome C was analyzed the same way as Ubiquitin. However, no graph 
could be obtained for the undigested Cytochrome C because of its large mass. The results for the 
digested Cytochrome C are shown below.  
Table 5 
m/z start  end Fragment sequence  
762.448 9 - 14 KIFVQK 
634.331 10 - 14 IFVQK 
1168.623 29 - 39 TGPNLHGLFGR 
1296.722 29 - 40 TGPNLHGLFGRK 
1584.736 40 - 54 KTGQAPGFSYTDANK 
1456.655 41 - 54 TGQAPGFSYTDANK 
795.406 81 - 87 MIFAGIK 
923.518 81 - 88 MIFAGIKK 
 
KIFVQK: (9-14) showed no oxidation on any of the graphs. Analyzing the structure of the 
protein shows that the F is buried. 
 
IFVQK: (10-14) is part of the above fragment and again shows no oxidation. 
 
TGPNLHGLFGR: (29-39) showed 2 oxidations at 1184 and 1200 Da for the 10 minute and 2 
hour reactions and the reaction with no iron. Looking at the structure shows that both the H and 
F are accessible.  
 
TGPNLHGLFGRK: (29-40) is an overlap with the above fragment and shows 2 oxidations 
agreeing with the above results. 
 
KTGQAPGFSYTDANK: (40-54) shows 1 oxidation at 1600 Da for the 10 minute reaction and 2 
oxidations for the 2 hour reaction with no iron. We predict the P and the Y were oxidized 
because both are on the surface of the protein.  
 
TGQAPGFSYTDANK: (41-54) is an overlap with the above fragment and also shows 1 
oxidation for both of the graphs. 
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MIFAGIK: (81-87) shows 2 oxidations at 811 and 826 Da for both reactions. The M is not on the 
surface but it may still be oxidized because it is so easy and its closeness to the Fe on the heme 
group. The F is on the surface. 
 
MIFAGIKK: (81-88) overlaps with the above fragment and also shows two oxidations. 
 
Results and Discussion 
 Oxidation using H2O2 was found to be slow and gentle. The reaction did succeed in 
oxidizing the BSA, but it took 2 weeks and even then the amount of oxidation was very small. 
The peptides showed the same results. When the oxidation was catalyzed by Fe the reaction 
oxidized over twice as much peptide in the same time interval than H2O2 alone. The oxidation of 
Ubiquitin with H2O2 alone showed that methionine was the main residue oxidized. This 
confirms the gentle oxidation capabilities of H2O2 because methionine is so easily oxidized. The 
mechanism for H2O2 oxidation is probably slow because the production of hydroxyl radicals 
without a catalyst is slow. Catalyzing the oxidation with Fe (III) proved effective. The Fe (III) 
was reduced to Fe (II) which in turn was able to cause OH. To be produced from the hydrogen 
peroxide. 
Fe2+ + H2O2  Fe3+ + OH. + OH-  
The results for Cytochrome C show very little difference in the amount of oxidation when 
the reaction catalyzed by Fe and when Fe is not present. A possible explanation for this is that 
the Fe already in the Cytochrome C is able to work as a catalyst. The Fe is in the heme group of 
Cytochrome C and may have enough mobility to be reduced and oxidized and thus work as a 
catalyst.   
 Our experiments showed protein mapping would be possible through oxidation analyzed 
by the MALDI-TOF-MS. Our results agreed with our assumptions that only certain residues 
would be oxidized and that those residues would have to be on the surface to oxidize. On the 
Ubiquitin we found oxidized methionine, proline, leucine, and tyrosine. On the Cytochrome C 
we found oxidized histidine, phenylalanine, proline, tyrosine and methionine. 
Future Research 
 The next step in this project is to confirm our predictins of where the oxidations occurred 
on the peptides and the proteins. This could be done using collision induced dissociation (CID) 
in the quadrupole ion trap mass spectrometer and also by using post source decay in MALDI-
TOF-MS. Once we confirm our results by using certain type of a fragmentation technique, we 
can proceed to oxidize larger proteins and proteins with an unknown crystal structures to 
determine their accessible residues. 
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Determination of the Effect of Magnetic Particles on Oxygen Reduction 
Potentials 
Michelle Reed, Adams State College 
Alamosa, Colorado 
 
 
Abstract 
 
Recently, a large interest in fuel cell research has developed.  The polymer electrolyte fuel 
cell system is one of many fuel cells currently being considered as an alternative power 
source for electric vehicles.  Of the performance controlling components in a polymer 
electrolyte fuel cell, the cathode is a critical component and its performance depends 
largely on oxygen’s transport rate and electron transfer kinetics.  If the oxygen 
overpotential can be reduced by a magnetic force, this would improve the performance of 
the fuel cell extensively3. Therefore, investigation of two different methods of adhering 
magnetic particles onto gold electrodes for their catalytic effect on oxygen’s reduction 
potential were carried out, both of which used silane-coated iron (II,III) oxide particles 
oriented in a magnetic field. The data that was collected indicates that when Nafion® is 
used as a polymer and cast with magnetic particles, there is no observable effect on the 
reduction of dissolved oxygen.  In the second method, magnetic particles were “trapped” in 
the electropolymerized eugenol.  It was determined that eugenol can be electropolymerized 
onto a gold electrode and then becomes impervious to ferricyanide, yet still permeable to 
oxygen.   The dissolved oxygen reduction peaks observed using magnetic particles also fall 
within the variance of peak potentials seen without magnetic particles, which implies no 
significant magnetic effect on the reduction of oxygen. 
 
Introduction 
 
The oxygen reduction reaction has been the focus of study for decades.  From a standard 
reduction potential table1, as seen below, there are five possible reactions which could be taking 
place. 2   
  
 Standard Oxygen Reduction Potential Reactions: 
  1. O2 (g) + 2H+ + 2e- → H2O2 
  2. H2O2 + 2H+ + 2e- → 2H2O 
  3. O2 + 4H+ + 4e- → 2H2O 
  4. O2 + H+ + e- → HO2 
  5. HO2 + H+ + e- → H2O2 
 
Recently, a large interest in fuel cell research has developed.  The polymer electrolyte fuel cell 
system is one of many fuel cells currently being considered as an alternative power source for 
electric vehicles.  Of the performance controlling components in a polymer electrolyte fuel cell, 
the cathode is a critical component and its performance depends largely on oxygen’s transport 
rate. Oxygen gas has paramagnetic properties, which cause it to be attracted toward a magnet.  
Research involving the magnetic attractive force towards O2 gas is referred to 
“magnetoaerodynamics”.  One of the promising applications of magnetoaerodynamics would be 
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the promotion of oxygen reduction reaction in polymer fuel cells, which is the major rate-
limiting process, and thus, causes high overpotential and loss of efficiency of the system3.  In this 
research the enhancement of oxygen reduction comes from a boost in mass transfer, and takes 
place at solid magnetic electrodes.  Other work by Leddy (unpublished) has indicated that the 
inclusion of magnetic particles on the electrode surface can speed the electron transfer kinetics 
and lower the overpotential necessary to reduce oxygen.4 
  
In this work, cyclic voltammetry (CV) was be used to investigate the catalytic effect of the 
magnetic particles on oxygen because if the overpotential has been reduced by the magnetic 
particles, then there will be a positive shift in oxygen’s reduction potential2.  If the oxygen 
overpotential can be reduced by a magnetic force, this will improve the performance of the fuel 
cell extensively3. Therefore, investigation of two different methods of adhering magnetic 
particles onto gold electrodes for their catalytic effect on oxygen’s reduction potential were 
carried out, both of which used silane-coated iron (II, III) oxide particles placed in a magnetic 
field.  These particles will be referred to as “magnetic particles” for the remainder of this paper.  
 
Experimental Procedures 
  
 Dissolved Oxygen (DO) Calibration2 
 
Electrodes: 
 
The solution used for the dissolved oxygen experiments was a 0.1 M KCl (Fisher Scientific, 
Pittsburgh, PA) made with reagent grade deionized water (Ricca Chemical Company, Arlington, 
TX).  The dissolved oxygen concentration was lowered by bubbling nitrogen gas (AirGas, 
Springdale, AR) through the solution.  The dissolved oxygen concentration was measured by 
using a YSI Instruments (Yellow Springs, Ohio) model 55 Dissolved Oxygen Meter.  Only 2 mm 
gold disk (CHI Instruments, Austin, TX) electrodes were used as working electrodes.  The gold 
disk electrodes were polished using 1.0 µm diamond polish, rinsing with deionized water 
followed by methanol (EMD Chemicals, Gibbstown, NJ), polishing again with 0.05 alumina, 
rinsing again with both water and methanol, and then sonicating before use in any cyclic 
voltammetry (CV) experiment.  The reference electrode was a saturated calomel electrode (SCE) 
and the auxiliary was a platinum flag.  All CVs were obtained on a CHI 650 potentiostat. 
 
Calibration Curves: 
 
Both the YSI DO meter and the electrodes were placed in the test solution.  Operation of the YSI 
DO meter requires the solution to be stirred for accurate measurement.  However, any CV 
experiment requires a static solution.  Therefore, the DO readings were only taken up to the point 
when stirring stopped and then CV experiments could be performed.  To construct a calibration 
curve for the working electrode, the test solution is first stirred with a Fisher Thermix Stirrer 
Model 120M at a speed of 4, while nitrogen is bubbled through the solution.  The gas flow is 
stopped around a DO reading of 0.10 mg/L and any bubbles clinging to the working electrode 
and DO meter are “knocked” off.  Bubbles on the electrode cause interference and prevent an 
accurate CV from being obtained.  The solution is kept stirring until the first YSI DO meter 
reading is taken at around 0.15 mg/L.  After recording the DO reading, the magnetic stirring is 
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then immediately turned off.  A CV is then collected after waiting approximately five seconds 
for the solution to settle.  CVs were performed from +0.5 V to -1.0 V at 0.1 V/s.  At the 
conclusion of the CV experiment, the magnetic stirrer is turned back on and the DO 
concentration is allowed to rise to the next reading without the addition of any added gasses.  
The process is continued until a DO reading close to 6.50 mg/L.  A calibration curve was then 
constructed from the CV data points at -0.60 V.     
 
 Nafion® with and without Magnetic Particles2 
  
Electrodes: 
 
The entire set-up was identical to the dissolved oxygen experiments. 
 
Casting: 
 
Nafion® membranes were cast on the working electrodes by pipetting 5 wt% Nafion® in alcohol 
solution (Aldrich, St. Louis, MO) onto the electrode surface and air drying for at least one hour.   
 
Iron (II,III) oxide particles 1-5 µm in size (Aldrich, St. Louis, MO) were coated by taking ~1 g of 
iron (II,III) oxide powder, and adding 10 mL of toluene and 10 mL 3-
aminopropyltrimethoxysilane (Aldrich).  This solution was shaken on a vortex shaker for four 
hours.  The particles were rinsed three times with 15 mL of toluene and then filtered.  The 
particles were dried in a dessicator and then scraped off the sides of the vial with a plastic 
spatula.  Then 10 mL of DI water and 10 mL ethylene glycol diglycidylether (tech. grade, 50%, 
Aldrich) was added and again the solution was shaken for four hours.  The particles were filtered 
and rinsed three times with DI water and then dried for two hours in a vacuum dessicator. 
 
The electrode film (casting) solutions were prepared by mixing the coated particles with the 
same Nafion® solution as above.  Films were formed using ratios of particles to Nafion®, such 
that different thicknesses and percent loading of particles was achieved.  These ratios of particles 
to Nafion® solution were calculated (based on densities) using an Excel spreadsheet provided by 
Dr. Johna Leddy’s group (See Figure 1).4 
 
Electrochemistry: 
 
The casting solutions for the iron particle catalyst were pipetted onto the working electrode and 
then a 0.05 T ring magnet was placed around the electrode.  The film was then dried for one hour 
while in the magnetic field.  The field lines of the ring magnet were facing upward during 
drying. 
 
The experimental set-up and calibration curves were constructed the same as in the DO 
experiments.  Some experiments were constructed for data collection only, so DO calibration 
curves were not constructed.  In these cases, DO readings were collected at only 4.00 mg/L to 
reduce experimental time. 
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Electropolymerization of Eugenol with and without Magnetic Particles 
 
Electrodes: 
 
The solution used for the electropolymerization of eugenol was a 10 mM eugenol (Alfa Aesar, 
Ward Hill, MA) made with 0.1 M sodium hydroxide (Fisher Scientific, Pittsburgh, PA).  
Working electrodes were always 2 mm gold disks.  The gold disk electrodes were polished using 
1.0 µm diamond polish, rinsing with deionized water followed by methanol (EMD Chemicals, 
Gibbstown, NJ), polishing again with 0.05 alumina, rinsing again with both water and methanol, 
and then sonicating before use in any cyclic voltammetry (CV) experiment.  The reference 
electrode was a saturated calomel electrode (SCE) and the auxiliary was a platinum flag.  Any 
dissolved oxygen collection was performed the same as in the DO experiments.  The same 
magnetic particles were used as in the Nafion® experiments.  
 
Electropolymerization5: 
 
An inverted cell was used to electropolymerize eugenol with and without magnetic particles (See 
Figure 2).  Eugenol was electropolymerized from +0.7 V to 0.0 V at 0.1 V/s for 40 sweep 
segments.  To determine if the electropolymerization of eugenol had been accomplished, 
exclusion of ferricyanide was tested using 10 mM ferricyanide (EM Science, Cherry Hill, N.J.) 
made with 1.0 M potassium nitrate (Fisher Scientific, Pittsburgh, PA).  CVs in the ferricyanide 
were performed from +0.8 V to -0.12 V at 0.1 V/s.  Two 0.05 T ring magnets were placed on the 
outside of the inverted cell when orientation of the magnetic particles was desired.  The magnets 
were arranged so that the field lines of the magnets would be opposing.  Microscope pictures 
were taken to determine if magnetic particles had been “trapped” in the polyeugenol film (See 
Figure 3). 
 
Dissolved Oxygen Permeability: 
 
The experimental set-up to detect dissolved oxygen permeability was the same as in the DO 
experiments.  All of the experiments were constructed for data collection only, so DO calibration 
curves were not constructed.  In these cases, DO readings were collected at only 4.00 mg/L to 
reduce experimental time. 
  
Results and Discussion 
 
Dissolved Oxygen: 
 
The dissolved oxygen experiments were performed to not only establish a calibration curve, but 
also to begin duplicating several of Dr. Jody Buckholtz’s experiments for her doctorate 
dissertation.  Her experimental results were worth duplicating because they showed a possible 
positive reduction potential shift for oxygen.2  Learning to collect CVs and using those to create 
accurate calibration curves was the first step to recreating Dr. Buckholtz’s experiments.  Figures 
4 and 5 show the data from the collection of DO CVs and the resulting DO calibration curve.  It 
should be noted that the appearance of the oxygen CVs was never consistent from day to day.  
Even when using the same electrode and test solution there were always some differences noted.  
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This is most likely due to changes in the test solution and/or electrode over time.  However, 
constructing calibration curves from peak currents at -0.6 V always provided linear calibration.2 
The results from the DO collection were near duplications of Dr. Buckholtz’s, which allowed the 
experiment to move onto the focus of polymers. 
 
Nafion® with and without Magnetic Particles: 
 
Nafion® is an oxygen-permeable polymer commonly used to coat the fuel cell cathode4. 
Dr. Buckholtz’s research indicates that magnetic particles in a Nafion® polymer coating can be 
used as catalysts.2 However, after duplication of Dr. Buckholtz’s experiments, there was no data 
to suggest that magnetic particles were acting as a catalyst.  Film thickness and percent loading 
of the Nafion®/magnetic particle coating were both analyzed to see if there was a variable 
dependence on the results.  No significant data was collected to support any positive shift for 
oxygen’s reduction potential.  The results did consistently show that the higher percentage of the 
magnetic particles in Nafion®, the larger the current (See Figure 6). Also, multiple gold 
electrodes have shown consistency, implying that regardless of gold electrode history, the same 
results are seen.  This consistency only held true when a plain Nafion® coating was used (See 
Figures 7-9).  When the magnetic particles are cast along with the Nafion® film, the consistency 
of the results disappears (See Figure 10). This was later found out to be due to an insufficient 
coating of the iron (II, III) particles with silane, based on the 2007 iron (II, III) silane-coating 
experiments performed by Dr. Emily Anderson.  The insufficient coating caused the particles to 
act as an additional electrode, which increased the overall area of the electrode6.  Later it was 
discovered by Dr. Anderson that repeating the coating procedure produced completely insulated 
particles. Due to the results of the Nafion® “duplication” experiments it was decided that a new 
polymer should be tried. 
 
Electropolymerization of Eugenol with and without Magnetic Particles: 
 
After observing no significant results using the Nafion® polymer, the focus of the research 
shifted to the eugenol polymer.  It was thought that the ionic nature of Nafion® could have been 
affecting the over results of the magnetic particle experiments, so eugenol was chosen because it 
has no charge.  The first goal of the experiments was to determine if eugenol could actually be 
electropolymerized onto the gold electrode.  After several electropolymerization experiments it 
became evident that eugenol could be electropolymerized onto gold.  This was seen by first 
collecting a bare gold CV in a ferricyanide solution to establish a reference CV.  Then the gold 
electrode was placed in the eugenol solution and electropolymerized for 20 sweep segments.  
The electropolymerized electrode was placed back into the ferricyanide and another CV was 
acquired.  This was repeated again with 40 sweep segments.  The results of the ferricyanide 
experiments clearly proved that eugenol had been electropolymerized onto the gold electrode 
because the CV of the ferricyanide current was dramatically reduced with 20 sweep segments 
and then zeroed after 40 sweep segments (See Figure 11).  The electrode coated with 
electropolymerized eugenol was then tested for oxygen permeability.  After it was established 
that electropolymerized eugenol was permeable to oxygen, several different gold electrodes were 
used, with one tested on different days, to see if consistent results could be established.  
However, as seen in Figure 12, eugenol is permeable to oxygen, but peak potential variability is 
large.  The DO reduction peaks observed varied anywhere between -0.4 V to -0.6 V.  Once this 
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variability was established, a method for “trapping” the magnetic particles in the eugenol had to 
be invented.  After several attempts using a standard cell set-up, an inverted cell was designed 
and tested.  The inverted cell worked very well for “trapping” the magnetic particles because it 
allowed the magnetic particles to rest directly on the electrode face.  As seen in Figure 3, the 
magnetic particles were successfully “trapped” while both oriented and unoriented.  However, as 
seen in Figure 13, the magnetic particle CVs do not show any observable difference in peak 
potentials between oriented and unoriented magnetic particles. 
 
Conclusions 
 
Dissolved oxygen detection was successfully measured and calibrated using the experimental 
procedures established by Dr. Buckholtz.2  The results the Dr. Buckholtz observed were not able 
to be reproduced during these sets of experiments.  The data that was collected indicates that 
when Nafion is used as a polymer and cast with magnetic particles, there is no observable effect 
on the reduction of dissolved oxygen.  It was determined that eugenol can be electropolymerized 
onto a gold electrode.  The electropolymerized eugenol is then impervious to ferricyanide and 
still permeable to oxygen.  Magnetic particles were “trapped” in the electropolymerized eugenol, 
but oriented and unoriented magnetic particles produce similar dissolved oxygen peaks. 
The dissolved oxygen reduction peaks observed using magnetic particles also fall within the 
variance of peak potentials seen without magnetic particles, which implies no significant 
magnetic effect on the reduction of oxygen. 
 
Even though it was initially thought that magnetic particles could potentially act as a catalyst and 
could cause a positive shift in oxygen’s reduction potential, the above mentioned experiments 
contradict those thoughts.   
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A B C D E 
Nafion® dry density (g/ml) 1.95 1 
Nafion® solution density (g/ml) 0.921 2 
Nafion® solution weight percent  5 3 
Electrode area (cm2) 0.283 4 
  5 
Film Thickness (microns) 4 6 
film loading (% vol) 25 7 
particle density (g/ml) 4.95 8 
       9 
Weight of particle for casting solution (g) 0.0068 10 
Volume of Nafion® solution for casting 
solution (mL) =D11*D15/D14 11 
  12 
Mass of particle in film (g) =D9*D5*D7*D8/1000000 13 
Volume of Nafion® solution (mL) in film 
=D2*D5*(D7/10000)*(1-
D8/100)*(100/D4)/D3 14 
    15 
    16 
    17 
Casting volume (mL) for modified electrode =D15+D14/D9 18 
  19 
Unmodified electrode casting volume (mL) =D5*(D7/10000)*D2*(100/D4)/D3 20 
 
Figure 1.  Excel spreadsheet provided by Dr. Johna Leddy’s group.  Rows 1-4 and 8 are all 
constants.  Changes made to rows 6, 7 and 10 determine the values for rows 11-20. 
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Figure 2.  Picture and description of the inverted cell used in the eugenol polymerization 
experiments. 
Bare gold 
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Figure 3.  Picture and description of the “trapped” magnetic particles versus a bare gold 
electrode.  Pictures taken with a microscope. 
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Figure 5.  Dissolved oxygen calibration curve for a bare 2 mm gold disk electrode using the 
current of -0.6 V from Figure 4. 
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Figure 6.  Cyclic voltammetry data for a 2 mm gold electrode with 25% loading of magnetic 
particles in various Nafion® thicknesses in 0.1 M KCl vs. SCE. 
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Figure 7.  Cyclic voltammetry data for a 8.35 µm Nafion® coated 2 mm gold electrode in 0.1 M 
KCl vs. SCE.  The dissolved oxygen concentrations are given in mg/L. 
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Figure 8.  Dissolved oxygen calibration curve for a 8.35 µm Nafion® coated 2 mm gold disk 
electrode using the current of -0.6 V from Figure 7. 
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Figure 10.  Cyclic voltammetry data in 0.1 M KCl vs. SCE for various 8.35 µm Nafion® coated 
2 mm gold electrodes with 10% loadings. 
 
 
Figure 11.  Cyclic voltammetry data in 10mM ferricyanide vs. SCE for 2 mm gold electrodes 
with various electropolymerized eugenol coatings. 
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Figure 12.  
Dissolved oxygen cyclic voltammetry data in 0.1 M KCl vs. SCE for 2 mm gold electrodes with 
electropolymerized eugenol coatings after 40 sweep segments. 
-electrode 1, day 1 
-electrode 1, day 2 
-electrode 1, day 3 
-electrode 3, day 2 
-electrode 4, day 2 
 79 
 
Figure 13.  Dissolved oxygen cyclic voltammetry data in 0.1 M KCl vs. SCE for 2 mm gold 
electrodes with electropolymerized eugenol and “trapped” particle coatings after 40 sweep 
segments. 
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Effects of Redox Magnetohydrodynamics on Anodic Stripping Voltammetry 
of Arsenic 
Adam Ring, Miami University 
Oxford, Ohio 
 
Abstract 
 
Redox Magnetohydrodynamics (MHD) has been used in conjunction with the anodic 
stripping voltammetry analysis (ASV) analysis of a solution containing 10-6 M As2O3 in 
order enhance detection sensitivity.  A large concentration of potassium ferricyanide (100 
mM) was added to the solution to create a large cathodic current, which when combined 
with the external magnetic field created a large Lorentz force to aid in stirring of the 
solution as was evident by an increased current in a cyclic voltammogram (CV) in the 
presence of a 1.55 T magnetic field.  However, there was no corresponding enhancement in 
the peak height for stripping waves of arsenic.  The effect of various deposition potentials 
for ASV has also been investigated, and it was found that the optimal deposition potential 
depends on the type of electrode being used.  Although MHD-enhanced ASV was not 
immediately successful for As, it has been shown to work for several other heavy metals, 
and should prove to be a valuable technique for As once it is optimized.   
 
Introduction 
 
 Arsenic is a toxic substance which exists in three inorganic oxidation states other than the 
ground state, ±3 and +5.  Of these, the inorganic +3 form is the most harmful while the +5 form 
is also considered dangerous.1  Inorganic arsenic has been found in drinking water in 20 
countries, including a major contamination in Bangladesh and India where 50 districts have 
reported arsenic levels above the World Health Organization’s (WHO) limit of 10 μg/L.2  
Ingestion of high levels of arsenic has been associated with increased rates of cancer as well 
liver, lung, and kidney disease.3  For this reason a quick, reliable, and safe method of arsenic 
detection is necessary.  Previous methods for arsenic determination include atomic fluorescence 
spectrometry and inductively coupled plasma, but these and other similar methods are generally 
not field portable.  The latest electrochemical methods for arsenic determination include anodic 
stripping voltammetry (ASV), anodic stripping chronopotentiometry (SC), and cathodic stripping 
voltammetry (CSV).4  These methods are much more portable and may also allow for the 
differentiation of As(III) and As(V) without special sample preparation, another drawback of the 
other methods.   
 
 Anodic stripping voltammetry (ASV) consists of two main steps: During the deposition, 
arsenic is reduced and accumulates on the electrode in its zero-oxidation form.  Arsenic is then 
oxidized off of the electrode during an anodic potential sweep, resulting in an anodic current.  
The current magnitude is related to the concentration of the arsenic in the starting solution.  This 
method has previously been used to analyze metals such as mercury, cadmium, copper, lead, and 
zinc.5-7  In this work, gold disk and gold microelectrodes were used, as gold has been shown to 
yield higher and sharper oxidation peaks than either hanging mercury drop or platinum 
electrodes.8 
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 If the solution is stirred during the deposition step of ASV, more analyte can be delivered 
to the electrode per unit time, thereby increasing sensitivity and lowering detection limits.  
Typically, stirring is achieved using mechanical methods such as a stir bar with stir plate or a 
rotating disk electrode.  However, the work described here focuses on the use of redox 
magnetohydrodynamics (MHD) to instead “stir” the solution, which is better suited for 
portability if the magnetic field is supplied by permanent magnets.  During MHD, a redox 
species in the analyte solution produces a large cathodic current, J (A/m2).  In the presence of a 
magnetic field B(T), this current produces a Lorentz force FL (N/m3), which points in the 
direction governed by the right hand rule: 
    
FL = J × B 
 
If this force induces convection across the electrode surface, it can deliver more solution and 
therefore analyte to the electrode per unit time, thereby increasing the quantity deposited in the 
concentration step, and thereby improving sensitivity and decreasing detection limits.6, 9, 10 
 
 The work described herein focuses on the use of MHD to increase the sensitivity of 
arsenic ASV.  Stripping was performed in the presence and absence of a magnetic field (0 T to 
1.77 T) on a solution containing 2 μM As3+,100 mM K3Fe(CN)6 as the pumping redox species, 
and 0.1 M HCl as the background electrolyte.  Studies were performed on both a 2 mm diameter 
Au disk as well as eight adjacent 25 μm wide (with 25 μm gaps and 2 mm long) Au bands which 
were shorted together on a microelectrode array. 
 
Experimental 
 
 Materials and Reagents:  All chemicals were used as received.  All solutions were 
prepared with high-purity deionized (DI) water (Ricca Chemical, Arlington, TX).  
Hexaammineruthenium (III) chloride (98%), potassium ferricyanide (99.99%+), iron (III) nitrate 
nonhydrate (99.99%+), and p-benzoquinone were purchased from Aldrich Chemical Co. (St. 
Louis, MO).  Potassium ferricyanide (99.0%) was acquired from EM Industries, Inc. 
(Gibbstown, NJ) and Arsenic (III) Oxide (99.5%) from Alfa Aesar (Ward Hill, MA).   
 
 The 2 mm Au disk was purchased from CH Instruments, Inc. (Austin, TX).  
Microelectrode arrays were created on site.  Each array chip is 1” x 1” and contains an array of 
16 individually-addressable microband electrodes. The band electrodes are 2 mm long with 
widths of 25, 50, or 100 μm, and the gaps between the electrodes are 25, 50, or 100 μm, 
respectively.  Photodefinable BCB was used to insulate the electrode leads (which connect the 
electrodes to the contact pads on the top of the array chip) to allow the bottom half of the array 
chip to be submerged in solution.11 
 
 Apparatus:  Characterization experiments were performed using both cyclic 
voltammetry (CV) and anodic stripping voltammetry (ASV).  These experiments were performed 
on an Electrochemical Workstation Model 750A (CH Instruments, Inc.)  A computer equipped 
with CHI-750A software was used to manage these experiments.  All experiments were run 
using a Ag/AgCl (saturated KCl) reference electrode and a platinum wire auxiliary electrode.  
Before each experiment, the potential was held at  +0.6 V for 35 s in order to remove As left over 
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from previous runs.  When using disk electrodes, the electrode was also further cleaned by 
polishing with 1 μm diamond (Bioanalytical Systems, Inc., West Lafayette, IN) and 0.05 μm 
alumina (Buehler, Lake Bluff, IL).  Sonication in DI water occurred following polishing with 
each grit size.   
 
 Experimental Set Up:  All electrodes were placed in a modified culture tube during 
experimental runs.  This tube was placed between the poles of an electromagnet (New England 
Techni-Coil) which were 3.3 cm apart for microelectrode array experiments.  After a bottom of 
the culture tube was removed using a razor blade, approximately 8 inches of Tygon tubing was 
epoxied (Devcon, Riviera Beach, FL) to the bottom of the tube in order to allow for removal of 
the redox species before stripping step commenced (Figure 1).  This set up varies slightly from 
the set up when using a disk electrode.  The smaller diameter of a disk electrode meant that these 
experiments were run in a smaller culture tube, which allowed the magnet poles to be placed 
closer together (2.8 cm).   In both cases, the flow through the tubing was controlled using a pinch 
clamp.  An EMS 100-50 power supply (Lambda EMI) was used to power the magnet, which was 
cooled by an Affinity F-series chiller (Lydall).  Because of 
the variance in distance between the poles of the magnet, a 
magnetic field of 1.77 T was used for experiments on Au 
disks, while a field strength of 1.55 T was employed for 
trials on the microelectrode array. 
 
 For both the disk experiments and the array 
experiments, an initial volume of ~8 mL was used.  A 
deposition potential ranging from -0.3 V to -1.1 V was 
applied for 240 s, at which point the washing step 
commenced.  During the wash, 2 mL of HCl was added to 
the tube and then drained off using the pinch clamp.  For the 
disk electrodes, washing occurred every 10 s starting at 240 
s and ending at 290 s.  The deposition potential remained 
constant throughout this entire washing process.  Care was 
taken so that the level of the solution never dropped below 
the level of the working and reference electrodes.  Stripping 
(0.1 V/s) commenced at 300 s.  For the microelectrode array experiments, the deposition time 
was significantly shorter (5 s to 60 s).  Washing occurred every 5 s until all redox species had 
been removed, as evidenced by a color change.  The redox species must be adequately removed 
before the stripping step because the high concentration of redox species produces a high 
cathodic background current which can interfere with viewing the stripping wave of As.   
 
 
 
 
Results and Discussion 
 
 Electrolyte determination:  HCl was chosen as the electrolyte for As ASV studies based 
on previous evidence.  It was reported in 1975 that HCl afforded better results than either 
Figure 1.  Experimental set up 
for trials which used 
microelectrode array.  Pinch 
clamp allowed redox species to 
be drained off.   
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sulfuric, nitric, perchloric, or phosphoric acids.8  
Stripping waves of 2 μM As2O3 were readily 
apparent in electrolyte only at a deposition potential 
of -0.3 V for 240 s on 2 mm Au disk electrodes 
(Figure 2).  This stripping wave has a peak current of 
-2.38 μA.  Decreasing the deposition time to 90 s 
yields a stripping wave with a 48% decrease in the 
peak current, and a deposition time of 15 s gives an 
88% decrease.  However, increasing the deposition 
time to 600 s only gives an 8% increase in peak 
current over a deposition time of 240 s.  These results 
indicate that there is a limit to the amount of As 
which can be deposited on the surface of subsequent 
ASV studies on Au disk electrodes.  This limit to the 
amount of As which can de deposited on may be due 
to As0, which has been shown to be non-conductive.12  
Arsenic in this oxidation state may build up on the 
electrode over the course of several experiments, which would decrease the area of the electrode 
which is available for subsequent electrochemistry. 
 
 Redox Species Determination: After reproducible stripping waves were obtained in 
electrolyte alone, different redox species for MHD studies were investigated.  Five were 
examined: Fe3+, Fe(CN)63-, p-benzoquinone, MnO4-, and Ru(NH3)63-.  In each case, a solution of 
2 μM As2O3 and 100 mM of the redox species was prepared in 1 M HCl.  These solutions were 
then evaluated by applying ASV with a deposition potential of -0.3 V for 240 s.  Each time, the 
stripping wave that was previously seen at about 0.2 V in electrolyte alone disappeared.  We 
suspect that this is because the E° value for these redox pairs was such that As3+ was being 
oxidized to As 5+ instead of being reduced to As0 and depositing on the electrode.  An 
appropriate redox species should have an E° value between that of As3+ and As5+.  Of the five 
species tested, only ferricyanide has this value, so more work was done to optimize ferricyanide 
as the redox species.   
 
 Since these experiments were being performed in acid, it was important to study the 
effects of H+ concentration on the E° of ferricyanide.    Four H+ concentrations were 
investigated: 1e-7 M, 0.01 M, 0.1 M, and 1.0 M.  A solution with 1e-7 M H+ has an E° of 0.23 V, 
0.01 M has an E° of 0.25 V, 0.1 M 0.35 V, and 1.0 M of about 0.30 V.  Since the listed E° value 
of ferricyanide is about 0.358 V, 0.1 M HCl was chosen because it is closest to this value.  All 
experiments involving ferricyanide were subsequently run in 0.1 M HCl.      
 
 ASV of As on gold disk electrodes:  Initially, As stripping waves were not seen in the 
presence of high concentrations of ferricyanide.  When concentrations in the millimolar range 
were used for both species, a CV response showed distinctive waves for both species.  Perhaps 
contaminants (such as Fe3+) in the ferricyanide become significant at the higher concentrations 
and react with the As3+, forming As5+.  However, when the deposition potential was switched 
from -0.3 V to -1.1 V, stripping waves reappeared, but these results were not very reproducible.  
The stripping waves would appear in one run, but not in the next, although the parameters did 
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Figure 2. ASV (0.1 V/s) of 2 μM 
As2O3 in 1 M HCl.  Deposition 
potential of -0.3 V for 240 s.  As 
stripping wave appears at about 0.2 
V.   
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not change.  Several approaches were taken in order to investigate some of these problems.  It 
was initially postulated that non-conductive As0 was depositing on the Au electrode and 
diffusing into the gold.  Holding the potential at 0.6 V may not have been enough to remove this 
excess As on the electrode.  More rigorous polishing procedures were implemented.  Polishing 
occurred with 15 μm diamond, followed by 6 μm diamond, then 1 μm diamond, and finally 0.05 
μm alumina.  However, this did not resolve the problems, and As stripping waves were still very 
irreproducible.  Next 99.999% pure HCl was acquired (Alfa Aesar, Ward Hill, MA) to avoid 
impurities in the HCl that could be participating in reactions with arsenic.  Unfortunately, this 
also did not resolve the problems.  Finally, the disk electrodes were immersed in 6 M HNO3 in 
order to remove any impurities that had deposited on the electrode.  After soaking the electrodes 
in HNO3 overnight, the electrodes were placed in 1 M HClO4 and nitrogen was bubbled through 
the solution.  Finally, a potential of 0.6 V was applied for 30 s.  Even after this extensive 
cleaning of the electrode however, arsenic stripping was not reproducible.  Finally, disk 
electrodes were abandoned and ASV studies began using microelectrodes. 
 
 ASV of As on microelectrode arrays: Stripping experiments on the micro scale proved 
to be much more effective than those on the milli-scale.  During these trials, As was deposited on 
a chip which contained 20 different electrodes.  Each electrode was 25 μm wide and 2.1 mm 
long, and there was also 25 μm between each electrode (Figure 3).  Each trial was performed 
with eight of these electrodes shorted together.  Since it had already been shown on the disk 
electrodes that arsenic was interacting with ferricyanide and producing inconsistent results, the 
interaction between As and ferricyanide on the micro scale was studied.  Since the peaks of As 
and ferricyanide are not predicted to overlap, it was expected that each of these solutions would 
yield the same peak height for As.  However, this was not the case on the disk electrodes as the 
As peak in the presence of ferricyanide was significantly reduced.  This again implies that 
ferricyanide is interacting with As in an unusual 
manner.  It was already shown that based on redox 
potentials, Fe3+ (a possible contaminant) will 
oxidize As3+ to As5+, shifting the E° for deposition 
of As0 to more negative potential values.  Since the 
redox species is present at a concentration 1000 
times greater than As, any small amount of Fe3+ 
would be enough to react with all of the arsenic, 
resulting in no stripping waves.  For this reason, 
99.99% pure ferricyanide was obtained and used.  
Solutions of 1 mM As2O3 in 0.1 M HCl and 1mM 
As2O3 and 100 mM K3Fe(CN)6 in 0.1 M HCl were 
prepared.  Even with pure ferricyanide, the As peak 
current was reduced by nearly 50% in the presence  
 
 
 
 
 
 
 
Figure 3. Close up of microelectrode 
array.  Each electrode is 25 μm wide by 
2.1 mm long.  The distance between 
electrodes is also 25 μm.  Eight 
electrodes were shorted together for 
each trial. 
175 μm { 
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of ferricyanide vs. a solution containing only As and no redox species (Figure 4).  
 
 Despite this work showing that ferricyanide 
continued to interact negatively with As, ASV was 
attempted using the Au microelectrodes.  First, an 
appropriate deposition potential was determined.  As 
was deposited at -0.3 V, -0.8 V, and -1.1 V in the 
presence of ferricyanide.  Of these, only a deposition 
potential of -0.3 V yielded reproducible As stripping 
peaks.  This is in direct disagreement with the data for 
disk electrodes, where a deposition potential of -1.1 V 
was used because no waves could be seen at -0.3 V or -
0.8 V.   
  A concentration study was then undertaken in 
order to determine the minimum concentration needed 
to see As stripping on microelectrodes with a deposition 
potential of -0.3 V.  Different concentrations of As2O3 
in the presence of 100 mM K3Fe(CN)6 in 0.1 M HCl 
were studied.  These concentrations ranged from 2 μM 
to 2 mM.  After As was deposited on the 8 adjacent Au 
electrodes, the ferricyanide was washed off and stripping commenced.  While the peak current 
increased with increasing As2O3 concentration (Figure 5), it did not increase linearly as would 
be expected (Figure 6).  
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 MHD:  After determining that ferricyanide was an appropriate redox species and 
working to get more reproducible data by switching to the micro scale for the working electrode 
and to -0.3 V for deposition, MHD studies finally began on As.  First, it was shown that in the 
Figure 4.  CV at 0.1 V/s of 1 mm 
As2O3 in 0.1 M HCl only (solid 
line) and 1 mm As2O3 and 100 mm 
99.99% pure K3Fe(CN)6 in 0.1 M 
HCl.  As peak height at ~ 0.18 V 
decreases nearly 50 % in the 
presence of ferricyanide. 
 Potential / V
vs. Ag/AgCl (saturated KCl)
-0.4-0.20.00.20.40.6
C
ur
re
nt
 / 
µ
A
-1.0
-0.5
0.0
0.5
1.0
1.5
2.0
2.5
Figure 5.  Varying concentration of As2O3 
in 100 mM K3Fe(CN)6 in 0.1 M HCl at 0.1 
V/s.  A deposition time of 5 s was used, 
and all ferricyanide was washed off before 
stripping began.  As peak current at ~0.18 
V increases with increasing As 
concentration. 
Figure 6.  Relationship of peak 
current to As2O3 concentration.  The 
arsenic peak at 0.18 V increases 
with increasing As2O3 
concentration, although it does not 
scale linearly. 
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presence of a magnetic field, the current did in fact increase, indicating Lorentz force-induced 
convection.  CV was run at 5 mV/s of 100 mM K3Fe(CN)6 and 2 μM As2O3 in 0.1 M HCl both 
in the presence and absence of a magnetic field (Figure 7).  After it was shown that MHD does in 
fact increase the current, ASV studies could begin.  As2O3 (2 μM) and 100 mM K3Fe(CN)6 in 
0.1 M HCl was deposited at -0.3 V for 60 s.  Washing then occurred every 4 s for 100 s.  
Stripping began at 160 s.  Unlike the CVs, ASV did not show an increase in the current and As 
peaks were the same height both in the presence and absence of a magnetic field (Figure 8).  This 
is inconsistent previous work which had shown that MHD would enhance striping waves of other 
heavy metals.  However, it is possible that the many oxidation states of arsenic, in comparison to 
those of the other heavy metals in aqueous solutions, like lead, copper, and cadmium, 
complicates the chemistry sufficiently to produce the unexpected results. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Conclusion 
 
 Unfortunately, an MHD enhancement was not observed for ASV of arsenic.  Peak current 
in the presence of a magnet is the same as in the absence of a magnet for As stripping.  However, 
work should continue in this vein in order to optimize the stripping of As in ferricyanide.  Work 
should continue using microelectrodes, as these have been shown to yield much more 
reproducible data than macro electrodes.  Also, work could begin on finding a new redox species 
which may yield more reproducible data than ferricyanide.  An appropriate redox species would 
have the following qualities: low cost, high purity, and appropriate E°. 
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Figure 7.  CV of 100 mM 
K3Fe(CN)6 and 2 μM As2O3 in 0.1 
M HCl.  Solid line is in a 
magnetic field with B = 1.55 T.  
Dashed line is not in a magnetic 
field.  The increased current in 
magnetic field, indicates Lorentz 
force induced convection.   
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Figure 8.   ASV of 100 mM 
K3Fe(CN)6 and 2 μM As2O3 in 0.1 
M HCl.  Solid line is in a 
magnetic field with B = 1.55 T.  
Dashed line is not in a magnetic 
field.  No increase in current is 
seen. 
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Synthesis & Racemization Studies of Chiral Pyrrolidines 
Roger Williams, Eastern New Mexico University 
Portales, New Mexico 
 
Introduction 
 
The world around us is chiral.  That is to say, the basic molecules of life are chiral; for 
example, naturally occurring amino acids have the (S) configuration, whereas naturally occurring 
sugars contain the (R) configuration1.  The importance of study in the area of chirality has grown 
significantly over the years, especially in the area of pharmaceuticals.  The chief reason for this 
interest lies with concerns on the types of physiological effects that different enantiomers have 
on the human body. Therefore, in the synthesis of pharmaceuticals, for those molecules which 
are chiral, it is important to have the correct configuration at each carbon for the molecule to be 
physiologically active. 
When this is not done, the consequences can be disastrous:  the classic example being the 
drug Thalidomide.  In the early 1960s, Thalidomide was prescribed to a multitude of pregnant 
women as a treatment to ease the effects brought on from morning sickness.  Unfortunately, due 
to a lack of knowledge about the drug’s chirality and the physiological effects of the different 
enantiomers, the resulting side effects held tragic consequences for those children born from 
women who had taken the drug during their pregnancy2. 
 
 
 
 
 
 
 
Figure (1):  (S) and (R) Enantiomers of Thalidomide 
 
Years later, it was found out, albeit too late, that the root cause of the teratogenic effects 
stemmed only from the (S) enantiomer; unfortunately, the drug prescribed was a racemic 
mixture.  Unfortunately in vivo, the (R) enantiomer is still able to racemize back to the (S) 
enantiomer3.  Therefore, in the synthesis of pharmaceuticals, it is important not only to be able to 
synthesize the right enantiomer, but also to understand its racemization kinetics.  More 
specifically, we are interested in the factors affecting the enantiomerization of the pyrrolidine 
(figure 2) below. 
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Figure (2): Racemization of 2-Li-N-Boc-Pyrrolidine 
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The previous study by Gawley et al.4 concentrated their efforts on this rate of 
enantiomerization in ether over a range of temperatures and determined its activation parameters.  
My particular project involves the synthesis, isolation, and characterization of both chiral and 
achiral molecules.  These are used as starting materials to understand the kinetics of racemization 
of carbanions generated from on the asymmetric deprotonation of pyrrolidines.   
 
In this present study, we are concerned with the effects brought on by the presence of 
following diamines:  N,N,N,N-tetramethylethylenediamine (TMEDA), N,N’-Diisopropyl-
Bispidine, and (-)-Sparteine.   
 
 
 
 
 
 
Figure (3):  Structure of TMEDA, N,N’-Diisopropyl-Bispidine, and (-)-Sparteine 
 
Experimental Procedures 
 
Starting Material Synthesis:  N,N’-Diisopropyl-Bispidinone 
N N
O
1) HCHO / AcOH / NH2
2) Reflux / MeOH / 18 Hrs
N
O
 
The synthesis starting materials began with the Mannich reaction forming N,N’-
Diisopropyl-bispidinone (or 3,7-Diisopropyl-3,7-diazabicyclo[3.3.1]nonane-9-one) 5.  The above 
synthesis was performed in the following fashion.  A 100 mL round bottom flask was oven dried 
and placed under Nitrogen; then, the following compounds were added: 30 mL of MeOH, 1.80 g 
(63 mmol) of paraformaldehyde, 1.30 mL (22 mmol) of acetic acid, and 3.00 g (21 mmol) of N-
isopropiperidone.  These compounds were allowed to stir at room temperature for 5 minutes 
under Nitrogen before continuing the synthesis.  Then, 1.80 mL (21 mmol) of isopropylamine 
was slowly added drop wise to the stirring solution.  The mixture was then heated to reflux for 
16 hours.    
 
After cooling the solution back to room temperature, the solvent was evaporated under 
reduced pressure.  Then 100 mL of 50% KOH (aqueous) was added to the resulting solution.  
The mixture was then extracted three times with 100 mL of diethyl ether.  The combined organic 
layers were then dried over a layer of magnesium sulfate, MgSO4, and evaporated under reduced 
pressure yielding a crude product.    In order to acquire enough N,N’-Diisopropyl-Bispidinone to 
continue the N,N’-Diisopropyl-Bispidine synthesis, the above synthesis was repeated at two 
times the present scale.   
M e 2 N 
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The products of the above procedures were combined, condensed, and dried under a high 
vacuum for 12 hours.  The resulting solution of N,N’-Diisopropyl-Bispidinone was then purified 
by fractional distillation at 110 oC under reduced pressure yielding a clear, oily liquid.  The 
product yield that was obtained was 69%.  Finally, the product was further analyzed by DEPT 
NMR, and 13C NMR. 
 
Figure (4):  13C NMR of N,N’-Diisopropyl-Bispidinone 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure (5): DEPT of N,N’-Diisopropyl-Bispidinone 
 91 
Starting Material Synthesis:  N,N’-Diisopropyl-Bispidine 
 
N N
O
N N
1) NH2NH2
2) KOH
 
 
After yielding enough purified N,N’-Diisopropyl-Bispidinone, the Wolff-Kishner 
reduction was completed in the following fashion5.  A 250 mL round bottom flask was oven 
dried and placed under Nitrogen; then, the following compounds were added:  20 g (320 mmol) 
of KOH and 60 mL of diethylene glycol, 4.60 g (20.5 mmol) of N,N’-Diisopropyl-Bispidinone.  
Finally, 3.6 mL (115 mmol) of anhydrous hydrazine was slowly added drop wise to the stirring 
solution at room temperature.  This mixture was heated to 180 oC and allowed to reflux for four 
hours.  
After cooling the solution back to room temperature, 100 mL of water was added to the 
solution.  The mixture was extracted four times using 50 mL of diethyl ether.  The combined 
extracts were then washed eight times with 80 mL of 20% aqueous solution of NaOH.   The 
combined ether extracts were then dried over a layer of magnesium sulfate, MgSO4, then 
concentrated under reduced pressure.  The resulting solution (N,N’-Diisopropyl-Bispidine) was 
then purified via fractional distillation yielding a clear, oily liquid.  The product yield that was 
obtained was 42%.  Finally, the product was further analyzed by GC/MS, DEPT NMR, and 13C 
NMR. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure (6):  13C of N,N’-Diisopropyl-Bispidine 
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Figure (7):  DEPT of N,N’-Diisopropyl-Bispidine 
 
In order to have enough starting materials for the experiment to follow, the above 
synthesis was carried out again.  The N,N’-Diisopropyl-Bispidinone synthesis was completed 
two times at two times the scale, and the N,N’-Diisopropyl-Bispidine synthesis was completed at 
normal scale to accommodate the amounts of N,N’-Diisopropyl-Bispidinone that was obtained. 
Starting Material Synthesis:  N-(tert-Butoxycarbonyl) Pyrrolidine (or N-Boc 
Pyrrolidine) 
 
 
The N-Boc-Pyrrolidine was synthesized through the subsequent methodology7.  A 500 
mL round bottom flask was oven dried; then, the following compounds were added to the flask: 
100 mL of chloroform (CHCl3) and 21.82 g (100 mmol) of di-tert-butyl-dicarbonate.  Through 
the use of a dropping funnel, 8.27 mL (100 mmol) of pyrrolidine was added drop wise to the 
stirring solution.  The solution underwent a significant exothermic reaction upon the addition of 
the pyrrolidine.  This solution was held and combined with the next reaction for completion. 
 
A 500 mL round bottom flask was oven dried; then, the following compounds were 
added to the flask: 200 mL of chloroform (CHCl3) and 43.64 g (200 mmol) of di-tert-butyl-
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dicarbonate.  Through the use of a dropping funnel, 16.54 mL (200 mmol) of pyrrolidine was 
added drop wise to the stirring solution.  The solution again underwent a significant exothermic 
reaction upon the addition of the pyrrolidine 
 
The resulting products were combined and refluxed for the 30 minutes.  After cooling to 
room temperature, the solvent of the combined product was then evaporated over a reduced, 
constant pressure.  The yield of N-Boc-Pyrrolidine that was obtained was >99%.  The product 
(N-Boc Pyrrolidine) was then analyzed by GC/MS. 
 
The racemic mixture of silanes (Scheme (1)) was used as the analytical standard for 
chiral stationary phase capillary GC.  The stannane (Scheme (2)) was used to generate the 
carbanion 2-(S) (Figure 2) for the kinetic studies.   
 
Scheme (1) – Synthesis of Racemic [(2)-Trimethylsilyl]-N-Boc-Pyrrolidine 
 
N
O tBuO
N
O tBuO
SiMe3
H
1) TMEDA / s-BuLi / -80 oC / 2 Hrs
2) Me3SiCl / 16 Hrs
 
                                                                               Racemic 
 
The racemic form [(2)-Trimethylsilyl]-N-Boc-Pyrrolidine was synthesized through the 
subsequent methodology of Beak6.  A 150 mL round bottom flask was oven dried and placed 
under Nitrogen; then, the following compounds were then added: 32 mL of diethyl ether, 1.6 mL 
(10.6 mmol) of N,N,N,N-tetramethylethylenediamine (TMEDA), and 1.4 g (8.2 mmol) of N-Boc 
Pyrrolidine.  The mixture was allowed to stir at –78 oC for ten minutes before continuing the 
synthesis.  Then, 9.6 mL (of a 1.4 M solution in cyclohexane, 10.6 mmol) of sec-BuLi was added 
slowly drop wise to the mixture.  This solution was allowed to continue stirring for two hours at 
–80 oC.  At the end of the two hours, 1.46 mL (10.6 mmol) of Me3SiCl was added to the 
mixture.  The resulting solution was allowed to warm over the next sixteen hours returning to 
room temperature. 
 
After the solution had returned to room temperature, it was washed with 20 mL of 5% 
aqueous H3PO4.  The aqueous layer was extracted and washed three times using 20 mL of 
diethyl ether.  The combined ether extracts were then washed with 50 mL of water containing 
three drops of NaHCO3.  The collected ether extracts were then dried over a layer of magnesium 
sulfate (MgSO4).  The extracts were then evaporated over a reduced constant pressure.   
  
The synthesis utilizing TMEDA was then completed again at the same scale previously 
indicated.  Once the second synthesis was complete both products were combined, condensed, 
and dried under a high vacuum for 4 hours.  The yield of racemic [(2)-Trimethylsilyl]-N-Boc-
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Pyrrolidine that was obtained was 60.2%.  The product was further analyzed by GC, see figure 
(8) below. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure (8):  TMEDA Racemic Standard 
 
Scheme (2) – Synthesis of (S)-[(2)-Tributylstannane}-N-Boc-Pyrrolidine 
 
N
O tBuO
N
O tBuO
SnBu3
H
1) (-) - Sparteine / s-BuLi / -80 oC / 5 Hrs
2) Bu3SnCl / 16 Hrs
er  = 97:3  
The (S) enantiomer of [(2)-Tributylstannane]-N-Boc-Pyrrolidine was synthesized through 
the subsequent methodology of Beak5.  A 150 mL round bottom flask was oven dried and placed 
under Nitrogen; then, the following compounds were added:  32 mL of diethyl ether, 2.4 mL 
(10.6 mmol) of (-)-Sparteine, and 1.4 g (8.2 mmol) of N-Boc Pyrrolidine.  The mixture was 
allowed to stir at –78 oC for ten minutes before continuing the synthesis.  Then, 9.6 mL (of a 1.4 
M solution in cyclohexane, 10.6 mmol) of sec-BuLi was added slowly drop wise to the mixture.  
This solution was allowed to continue stirring for five hours at –80 oC.   
 
At the end of the five hours, 2.86 mL (10.6 mmol) of Bu3SnCl was added to the mixture.  
The resulting solution was allowed to warm over the next sixteen hours returning to room 
temperature.  After the solution had returned to room temperature, it was washed with 50 mL of 
2M aqueous HCl.  The aqueous layer was extracted and washed three times using 50 mL of 
diethyl ether.   
 
The combined ether extracts were then washed with 50 mL of aqueous saturated KF 
solution.  The collected ether extracts were then dried over a layer of magnesium sulfate 
(MgSO4).  The resulting mixture was then evaporated over a reduced pressure.  The synthesis 
utilizing (-)-Sparteine was then completed again but at four times the scale previously indicated.  
Once the second synthesis was complete both products were combined. Finally, the product was 
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further purified by column chromatography using hexane as the solvent.  The yield of (S)-[(2)-
Tributylstannane}-N-Boc-Pyrrolidine that was obtained was 72%.  The product was further 
analyzed by GC. 
 
The Kinetic Methods 
Method (1):  
The Sn/Li Exchange4,8 methodology was used while studying racemization of 
organolithiums in the presence of N,N’-Diisopropyl-Bispidine and TMEDA.  Each kinetic run 
was prepared by charging nine tubes (oven dried) with two milliliters each of a 0.0439M stock 
solution of (S)-N-Boc-Pyrrolidine stannane.  The organolithium was generated by the addition of 
N-butyllithium to a cooled solution of (S)-N-Boc-Pyrrolidine stannane.    
 
 
 
Figure (9):  Presumed Coordination of N,N’-Diisopropyl-Bispidine to 2-Li-N-Boc-
Pyrrolidine 
 
 
 
Figure (10):  Presumed Coordination of TMEDA to 2-Li-N-Boc-Pyrrolidine 
 
Reaction is started by adding 0.2 ml of a cooled (-80 ˚C), premixed, 1:1 solution of n-
BuLi (2.5M) + N,N’-Diisopropyl-Bispidine (2.5M) to a cooled (-80˚C) solution of stannane in 
ether; the tubes are then placed in a thermostatted acetone bath, and a stopwatch started.  Tubes 
were removed at t= 10min, 30min, 3hrs, 4hrs, and in each case cooled to -80 ˚C, prior to 
quenching with exactly 0.2 ml of a 2.5M solution of TMSCl in hexane.   
The workup was then carried out on each of the nine tubes.  One milliliter of water was 
added and the ether layer was extracted.  The aqueous layer was then washed three times with 
two mL of diethyl ether.  The ether extracts were collected, dried over a bed of anhydrous 
MgSO4, and filtered.  The ether extracts were then evaporated over reduced pressure.  The 
product silane was then separated from the crude ethereal solution on silica TLC plates, eluting 
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with 6% EtOAc/Hexane.  The silane band was removed, extracted into diethyl ether, and 
analyzed by chiral stationary capillary gas chromatography. 
 
Method (2):   
 
This method was used for studying the racemization of the carbanion (N-Boc-
Pyrrolidine) in the presence of (-)-Sparteine5.  The organolithium was generated by the addition 
of sec-butyllithium to a cooled solution of (S)-2-(Tributlstannyl)-N-Boc-Pyrrolidine.  Each 
subsequent kinetic run was completed by injecting nine tubes (desiccated) with two milliliters 
each of a stock solution of N-Boc-Pyrrolidine (0.040 M) and (-)-Sparteine (0.045 M) in a diethyl 
ether solution over Nitrogen.   
 
Each of the nine tubes was then cooled to -80 ˚C before the addition of sec-BuLi 
occurred.  The procedure was started by adding 0.51 mL of a cooled (-80 ˚C) sec-BuLi (1.4 M in 
cyclohexane, 0.72 mmol) to each of the cooled nine tubes.  Once the s-BuLi was injected, the 
tubes are left for five hours at -80 ˚C.   
 
Once the five hours had elapsed, eight tubes are placed into a temperature controlled 
acetone bath, and the stopwatch started.  The t= 0 tube remains at -80 ˚C.  The tubes were then 
removed from the bath once the at t= 15 minutes, 30 minutes, 45 minutes, one hour, 1.5 hours, 2 
hours, 3 hours, and 4 hours.  When each tube was removed from the bath, it was cooled back 
down to -80 ˚C prior to quenching with 0.40 mL of TMSCl (2.5 M in hexane). 
 
The workup was then carried out on each of the nine tubes.  One milliliter of water was 
added and the ether layer was extracted.  The aqueous layer was then washed three times with 
two milliliters of diethyl ether.  The ether extracts were collected, dried over a bed of anhydrous 
magnesium sulfate (MgSO4).  The ether extracts were then evaporated over a reduced constant 
pressure.  The product silane was then separated from the crude ethereal solution on silica TLC 
plates, eluting with 6% EtOAc/Hexane.  The silane band was removed, extracted into diethyl 
ether, and analyzed by chiral capillary gas chromatography on an HP 5890 chromatograph 
 
Data Results & Discussion 
 
The chromatograms below, figures 12 through 15, show the enantiomerization kinetics 
for the process 2-(S) 2-(R) (See Figure 2) for a typical kinetic run.  
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Figure (12): TMEDA Run (252K) T = 0 sec 
 
 
 
 
 
 
 
 
 
 
 
 
Figure (13): TMEDA Run (252K) T = 300 sec 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure (14):  TMEDA Run (252K) T = 1800 sec 
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Figure (15): TMEDA Run (252K) T= 2700 sec 
 
Knowing the initial concentration of stannane used (for example 0.0439M), the above 
data allows us to calculate [R] as a function of time.  A plot of 1/2[ln ((Total Concentration) -
2R)] against time (in seconds) affords the rate constant for the reaction as obtained by the trend 
line (k = -{slope})9,10.  The data was then compiled in a table and a graph was generated from its 
results.   
 
Table 1:  Data from previous chromatographs (TMEDA Run at 252K). 
 
t/s R:S [R]/mol·L-1 1/2[ln(0.0439-2R)] 
0 4.44:95.56 1.90 X 10-03 -1.61 
300 6.30:93.70 2.80 X 10-03 -1.63 
1800 19.01:80.99 8.30 X 10-03 -1.80 
2700 23.67:76.33 1.05 X 10-02 -1.89 
 
The complete data graph for reactions with TMEDA is below: 
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The complete (-)-Sparteine and N,N’-Diispropyl-Bispidine kinetics data are shown in the graphs 
below. The graphs clearly show that with an increase of temperature the rate of 
enantiomerization increases: 
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Thermodynamics 
Through using the above data, we are able to construct Eyring Plots.  From them, 
the thermodynamic parameters were determined.  By plotting (1/T)/K-1 versus ln[k/T] from 
the above data, we are able to derive the enthalpy of activation (∆H‡) and the entropy of 
activation (∆S‡) for a reaction.9,10 
Using the trend line generated from the Eyring plot (y=mx + b), we can utilize the 
following formulas to obtain the said information:   
 
Slope = (- ∆H‡)/R 
Intercept = (∆S‡/R) + ln [k/h] 
Where “R” is the gas constant, “k” is the Boltzmann constant, and “h” is Planck’s 
constant.    
 
The data was compiled from all kinetics runs regarding the effects on activation 
parameters for the racemization of 2-Li-Boc-Pyrrolidine in the absence a diamine and in the 
presence of one of the following diamines: TMEDA, N,N’-Diisopropyl-Bispidine (aka 
Bispidine), or (-)-Sparteine.  The compiled data table is as follows: 
 
Table 2: Compiled Results of All Kinetics Runs  
 
Diamine Present T/oC T/K (1/T)/K-1 k/10-4s-1 ln[k/T] 
None4 -33 240 4.17 X 10-03 0.0746 -17.3 
None4 -26 247 4.05 X 10-03 0.276 -16.0 
None4 -25 248 4.03 X 10-03 3.33 -15.8 
None4 -17 256 3.91 X 10-03 3.66 -13.4 
TMEDA -26 247 4.05 X 10-03 0.447 -15.5 
TMEDA -21 252 3.97 X 10-03 1.10 -14.6 
TMEDA -17 256 3.90 X 10-03 2.14 -14.0 
Bispidine -22 251 3.98 X 10-03 0.501 -15.4 
Bispidine -19 254 3.94 X 10-03 0.835 -14.9 
Bispidine -15 258 3.88 X 10-03 1.82 -14.2 
(-)-Sparteine -18 255 3.92 X 10-03 0.493 -15.4 
(-)-Sparteine -13 260 3.85 X 10-03 0.832 -14.9 
(-)-Sparteine -5 268 3.73 X 10-03 2.71 -13.8 
 
The resulting Eyring plots generated from the above Table 2 are as follows: 
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Eyring Plot for the Racemization of N-Boc-
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Eyring Plot for Racemization of N-Boc-
2-Li-Pyrrolidine in Ether & TMEDA
y = -10219x + 25.883
-15.8
-15.6
-15.4
-15.2
-15
-14.8
-14.6
-14.4
-14.2
-14
-13.8
-13.6
0.00385 0.0039 0.00395 0.004 0.00405 0.0041
(1/T)/K-1
ln
[k
/
T
]
 102 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Eyring Plot for Racemization of N-Boc-2-Li-
Pyrrolidine in Ether & Bispidine
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Eyring Plot for Racemization of N-Boc-2-Li-
Pyrrolidine in Ether & (-)-Sparteine
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From the above Eyring plots, we are now able to calculate the activation parameters (∆H‡ 
and ∆S‡) for the racemization of N-Boc-2-Li-Pyrrolidine in the presence and absence of 
diamines.  Through using the calculated activation parameters and the following formula (∆G‡= 
∆H‡-T∆S‡), 9, 10 we can calculate the free energy of activation (∆G‡) for the racemization process 
at -78 oC (195K). The values are tabulated below. 
 
Table 3:  Compiled Thermodynamic Results 
 
Diamine Present ∆H‡/ kcal·mol-1 ∆S‡ /cal·mol-1K-1 ∆G‡/ kcal·mol-1 
None4 29.1 39.8 21.3 
Bispidine 25.0 22.2 20.7 
TMEDA 20.2 4.42 19.3 
(-)-Sparteine 17.4 -9.17 19.2 
 
Compiled Eyring Plots for 
Racemization of N-Boc-2-Li-
Pyrrolidine in Presence and Absence 
of Diamines
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Conclusion 
 
The enthalpy of activation (∆H‡) is a measure of the energy required to break bonds 
going from the ground state to the transition state.9,10   For our enantiomerization, the ∆H‡ values 
are all lower in the presence of diamines.  This implies that the energy required to break the C-Li 
bond is less when Li is coordinated to a diamine.  This leads to the clear prediction that the C-Li 
bond in the ground state will be longer when the Li is coordinated.   
 
The mechanistic significance of entropies of activation (∆S‡) is fraught with difficulty.  
To put it simply, a positive ∆S‡ implies an increase in disorder in going from the Ground State 
(GS) to the Transition State (TS); conversely, a negative ∆S‡ signifies an increase in order in 
going from the GS to the TS.9,10  The simplest way to interpret the term “disorder” is in degrees 
of solvation. The ∆S‡ values for our racemization are all smaller in the presence of diamines.  
Therefore, the difference in solvation between GS and TS decreases.  In the unique case of (-)-
Sparteine the negative ∆S‡ compels us to conclude that the TS must be more solvated than the 
GS.  Alternatively, the change in ∆S‡ values might reflect a change in the rotational freedom of 
the bulky t-Boc group upon coordination of the Li by the diamine. Clearly, molecular modeling 
could shed some light on these conclusions. 
 
Lithiation reactions are carried out at -78 oC (195K).  Unfortunately, the rate of 
racemization is too slow to follow at this temperature.  However, knowing the activation 
parameters above, we can calculate the Free Energy of Activation (∆G‡) for the racemization at -
78 oC (195K).  As represented in Table 3, the data forces us to the conclusion that all three 
diamines will speed up the rate of racemization under actual synthetic conditions.   
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and Hydrophobic Interaction Chromatographies. 
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Abstract 
 
 Protein purification was investigated using a combination of immobilized metal 
affinity chromatography (IMAC) and hydrophobic interaction chromatography (HIC) to 
potentially eliminate impurities in order to simplify the overall purification process of 
recombinant proteins.  The purpose of this study was to identify the proteins that bind 
during both chromatography steps in order to assess which genes in the bacteria are 
needed, and which ones can be eliminated, in order for the bacteria to still grow and 
produce the target protein.  Specifically, a BL21 strain of Escherichia coli was examined via 
IMAC, using divalent cobalt as an affinity ligand, to isolate nuisance proteins.  These 
contaminants were then applied to an octyl HIC column, and the proteins that bind and 
elute during this step were characterized. 
 
Introduction 
 
 The term proteomics refers to the protein level analysis of gene and cellular function in 
order to better understand the biochemistry of organisms.  Previous studies have demonstrated 
that immobilized metal affinity chromatography (IMAC) is an effective method used in 
proteomics to increase the sensitivity and resolution of protein separation.[1]  One of the major 
appeals of IMAC is that a specific protein can be isolated from a protein mixture based on its 
affinity to a particular ligand within a column.  There are, however, some limitations in that 
some impurities still remain in the column, requiring multiple steps in the purification process.  
By first using a combination of chromatography methods to isolate contaminants, then 
evaluating proteomic information, it could be possible to better identify the function of the 
contaminating species in the metabolic process, which could lead to a better understanding of 
which proteins are needed in order for the bacteria to grow and still produce the protein of 
interest.  Thus the idea is to “work backwards” to improve the downstream process of 
purification and concentration.  If the bacteria could be altered so that these nuisance proteins are 
not produced, it could lead to a considerable improvement of IMAC efficiency and minimize the 
overall purification process. 
In this study a BL21 strain of E. coli was prepared and a combination of Co(II) IMAC 
and HIC was used isolate nuisance proteins.  IMAC was done in high salt concentration to 
promote protein adsorption via selective binding to histidine.  In HIC proteins bind the non-polar 
groups attached to a hydrophilic polymer backbone at high concentration and elute by decreasing 
the salt content.  Once proteins that bind during both the IMAC and HIC steps are identified, it 
will be possible to begin developing guidelines to deal with these proteins in an effective manner 
so that the overall purification process can be simplified and more efficient. 
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Experimental Procedures 
 
Fermentation 
 A strain of E. Coli, BL21, was grown in Lauria Bertani (Difco) medium.  This was done 
by obtaining a colony from a freezer stock solution and placing it in an LB plate, which was then 
grown overnight in incubator at 37◦C.  A 20 g/L solution of LB was mixed, then autoclaved.  
After an overnight growth period, a single colony was isolated from the plate using a loop and 
transferred to 5 mL of the LB solution, which was stored in a bioreactor at 37◦C for 5 or more 
hours.  The 5 mL culture was used to inoculate 200 mL LB solution, and then stored at 37◦C.  
After an overnight growth period, an optical density reading was taken with a spectrophotometer 
at 600 nm.  Once it grew to around 1-2 OD the culture was centrifuged to recover the pellet.  The 
supernatant was poured off and the pellet was resuspended in 10 mL IMAC buffer and stored at -
20◦C.  Once frozen, the pellet was then thawed, lysed via sonication, and refrozen 3-4 times. 
This process was repeated several times to obtain enough sample volume for use in 
IMAC.  The lysed pellets were combined and centrifuged at 4◦C and 16,000 RPM’s for 15 
minutes.  The lysate was retained for chromatography and stored at -20◦C. 
 
Immobilized Metal Affinity Chromatography 
Two buffer solutions were made of 1.0 M NaCl and 0.05 M Na2HPO4.  The pH of each 
buffer was adjusted so that one solution had a pH of 7.4 and the other had a pH of 5.5, and both 
solutions were autoclaved.  A 5 mL HisTrap HP IMAC column (Amersham Biosciences) was 
charged with a 50 mM solution of cobalt chloride.  This was done by using a syringe to wash the 
column first with Milli-Q water, saturate it with the CoCl2 solution, and wash it again with 20 
mL Milli-Q water. 
Chromatography experiments were performed using an AKTA™ FPLC system 
(Amersham Biosciences).  Absorbance was monitored at 280 nm to determine when protein 
eluted from the column.  A ~20 mL sample of BL21 lysate was filtered using a syringe filter and 
loaded into the sample loop.  The column was first equilibrated with ~5 column volumes of 
IMAC buffer A (pH 7.4), and the lysate was injected into the column at a flow rate of 0.5 
mL/min.  After proteins were given time to bind the column and unbound proteins were washed 
out with buffer A (UV readings returned to baseline), the proteins that bound to the cobalt in the 
column were eluted using IMAC buffer B (pH 5.5) and collected in 10 mL fractions.  The 
samples were then concentrated using an Amicon Ultrafiltration system and stored at -20◦C for 
use in HIC step. 
 
Hydrophobic Interaction Chromatography 
HIC buffer A was prepared at 1.0 M NaCl and 0.05 M Na2HPO4 and buffer B at 0 M 
NaCl and 0.05 M Na2HPO4.  The pH of both buffers was adjusted to 7.4 and the solutions were 
autoclaved.  A 10 mL concentrated sample from IMAC was loaded into the FPLC and a 1 mL 
HiTrap Octyl FF HIC column (GE Healthcare) was equilibrated with HIC buffer A (1 M).  
Absorbance was monitored as before.  The sample was injected into the column at a flow rate of 
0.5 mL/min and allowed time to bind the column.  Unbound protein was washed out with buffer 
A for 6 column volumes.  Once UV readings reached baseline, bound proteins were eluted using 
buffer B (0 M) and collected in 5 mL fractions.  The fractions were stored at -20◦C. 
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DC Assay and Electrophoresis 
 The elution fractions were concentrated via centrifugation using 5000 MW Vivaspin 2 
mL concentrator tubes (VivaScience) and DC Protein Assay (Bio-Rad) was performed according 
to the manufacturer’s protocol to determine the protein concentration in the samples.  
Spectrophotometer readings were taken at 750 nm after a reaction time of 15 minutes.  Sodium 
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was run using the sample from 
the HIC step and BenchMark™ Ladder.  A 12.5% resolving gel with stacking layer was poured 
by hand.  Samples were mixed with equal amount of loading dye and placed in gel wells.  
Electrophoresis was run at 250V for 35 minutes, and the gel was removed and placed in 
Coomassie Blue stain overnight.  The gel was then soaked in destaining solution to visualize 
protein bands. 
 
Results and Discussion 
 
Fermentation 
 Approximately 1.5 liters of BL21 were grown.  After lysis and centrifugation ~65 mL of 
cell lysate was collected.  DC Assay protocol was followed and an optical density reading at 750 
nm found protein concentration of the lysate to be 2.85 mg/mL. 
 
Immobilized Metal Affinity Chromatography 
Figure 1 is an example recording of the IMAC step.  Buffer A (pH 7.4) was used to 
equilibrate the column 
preceding sample injection.  
20 mL (57 mg) of sample 
were loaded into the system 
at a time.  Once the sample 
was injected most of the 
proteins flow through and 
do not bind the column as 
represented by the change 
in absorbance (large peak 
between 0 and 20).  As the  
buffer (pH 7.4) flows  
through the system 
unbound proteins continued 
to wash out.  Once the UV 
readings returned to zero the 
elution buffer (pH 5.5) started through the column.  Fractions were being collected, which 
contain contaminant proteins.  Fractions 1, 2 and 3 were collected for a total volume of 30 mL.  
The samples were combined and concentrated to 10 mL.  DC Assay was performed and found 
the concentration to be 620.7 μg/mL.  Samples were stored at -20◦C for use in HIC. 
 
Figure 1.  Protein binding and elution profile during IMAC. 
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Hydrophobic Interaction Chromatography 
Figure 2 is an example recording of the HIC step.  Buffer A (1 M NaCl) was used to 
equilibrate the column 
preceding sample 
injection for 3 column 
volumes.  A 10 mL (6.21 
mg) sample from IMAC 
(the peak which emerged 
at 40 minutes) was 
injected into the column 
and given time to bind, 
shown by change in 
absorbance between 0 
and 30.  Unbound 
proteins were washed out 
with 6 column volumes 
of buffer A until the 
absorbance reached baseline, and the 
system switched to elution buffer (0 M 
NaCl) and fractions were collected.  Fraction 3 was retained for electrophoresis. 
 
DC Assay and Electrophoresis 
 DC Assay manufacturer protocol was followed and spectrophotometer readings at 750 
nm were used to determine the protein concentration in the IMAC and HIC elution fractions.  
Calculations were performed and are summarized in Table 1.  
 
 
 
 
The sample from the HIC elution was concentrated via centrifugation the protein 
concentration was determined to be 645.9 μg/mL.  Fifteen microliters (15 μL) of the sample and 
15 μL of dye were mixed with 7 μL applied to a SDS-PAGE gel.  BenchMark Ladder was loaded 
in lane 1.  After observing the results from electrophoresis (Figure 3) and comparing the protein 
sample to the BenchMark™ Ladder, it was determined that there were 10-12 proteins between 
50 and 220 kDa and approximately 3 proteins between 20 and 50 kDa that bound after both 
steps.  These proteins are very dilute.  Interestingly, there was one intense band around 50 kDa 
which obviously represents the bulk of protein present in the HIC elution pool. 
 
Samples Protein 
Concentration 
Sample Volume Amount of Protein 
in Sample 
Percentage of 
Original Protein 
Extract 2.85 mg/mL ~50 mL 57 mg (20mL) 
loaded into IMAC 
100% 
After IMAC 213 μg/mL 30 mL 6.38 mg 11% 
After HIC 145 μg/mL 5 mL 0.72 mg 1% 
Figure 2.  Protein binding and elution profile during HIC. 
Table 1.  Amount of protein in fractions collected after elution and percentage or original 
protein retained after chromatography steps. 
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Conclusion 
 
 It was concluded from the results that immobilized metal affinity chromatography 
followed by hydrophobic interaction chromatography yielded almost no cellular proteins as 
potential contaminants.  There was one major contaminant protein that binds during both Co(II) 
IMAC and HIC in high abundance.  This means that a simple, 2-step purification process can be 
designed to isolate recombinant protein via IMAC/HIC combination.  Once the major 
contaminant is identified, its role in metabolism can be assessed.  If the gene is non-essential, it 
can be deleted from the original strain.  If it is essential, continuing work would involve altering 
the number of surface exposed histidines in the wild type protein to remove the IMAC binding 
motif, thus simplifying the overall purification process of the target protein. 
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